2009

The Black AIDS Institute Kicks Off Its National Platform to Build Black AIDS Awareness in Atlanta, GA: PRNewswire - December 30, 2009; ATLANTA, Dec. 30 /PRNewswire-USNewswire/ -- Martin Luther King Jr. weekend marks the kick-off of the Black AIDS Institute s National Trump AIDS Bid Whist Tournament with a Qualifying Tournament and Health Fair in Atlanta, GA. The Black AIDS Institute and the 7 NO! Players of Atlanta, the original hosts of the Bid Blind
Charmin's 'Bathrooms over Broadway' is Broadway's First-Ever Bathroom Musical Starring Tony-Award-Nominated Christopher Sieber of 'Shrek the Musical': PRNewswire - December 29, 2009; NEW YORK, Dec. 29 /PRNewswire/ -- For tourists, local New Yorkers and avid lovers-of-the-arts alike, the best seats on Broadway this holiday season are in the Charmin Restrooms! Charmin® has teamed up with non-profit Broadway Cares/Equity Fights AIDS to present Bathrooms over Broadway, the first-ever Broadway show in a
Third Annual Report on Orphans and Vulnerable Children in Developing Countries Released Today: PRNewswire - December 23, 2009; WASHINGTON, Dec. 23 /PRNewswire-USNewswire/ -- The U.S. Government released today a report on assistance to highly vulnerable children in developing countries, U.S. Government and Partners: Working Together on a Comprehensive, Coordinated and Effective Response to Highly Vulnerable Children. Seven federal departments a
Tibotec Virco Virology BVBA Acquires LAB TRACKER(TM) HIV Electronic Medical Record Software System from Ground Zero Software: PRNewswire - December 15, 2009; -- Acquisition Expands Health Information Technology Offering from Virco and Reinforces Commitment to the Fight Against HIV/AIDS BRIDGEWATER, N.J, Dec. 15 /PRNewswire/ -- Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the com
Grey Goose Hosts a Night of Glamour and Celebrity Style: Grey Goose Character & Cocktails the Elton John AIDS Foundation Winter Ball: PRNewswire - December 15, 2009; LONDON, Dec. 15 /PRNewswire/ -- Grey Goose (www.greygoosecharacter.com), the vodka with character, partnered with the Elton John AIDS Foundation on Sunday night for the third consecutive year to host the most glamorous social event of the season with Sir Elton John and David Furnish. This unforgettable night of style a
AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial: PRNewswire - December 14, 2009; -- Funding and Support for HIV Prevention Research Must Continue NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Microbicides Development Programme announced earlier today that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 m
Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health: PRNewswire - December 10, 2009; WASHINGTON, Dec. 10 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi issued the following statement today applauding the inclusion of language in the fiscal year 2010 Consolidated Appropriations Act lifting the ban on federal funding for syringe exchange initiatives to prevent the spread of HIV. The omnibus bill passed
Emmy Award Winning Actress Debra Messing Visits Zimbabwe: Helps PSI, DFID and USAID highlight progress in the fight against HIV/AIDS: PRNewswire - December 10, 2009; HARARE, Zimbabwe , Dec. 10 /PRNewswire-USNewswire/ -- Emmy Award winning actress and PSI (Population Services International) Ambassador Debra Messing is in Zimbabwe celebrating organizations, donors and individuals who have contributed to the substantial decline in HIV prevalence rates in the country. Over the past six
Human Rights Denied: Obama Leaves 75 Million Children Behind: PRNewswire - December 10, 2009; A well-resourced Global Fund for Education in 2010 will bring the world one giant step closer to assuring human rights for all. - Dr. Paul Zeitz WASHINGTON, Dec. 10 /PRNewswire-USNewswire/ -- Today is International Human Rights Day, commemorating the 61st anniversary of the Universal Declaration of Human Rights which
Black Community Unites Against HIV/AIDS Epidemic: PRNewswire - December 10, 2009; DETROIT, Dec. 10 /PRNewswire-USNewswire/ -- African-American political leaders, union members, ministers and community activists are meeting Monday, December 14th to create and implement a strategy to combat the deadly HIV/AIDS virus in the African-American Community. Detroit is leading the nation in murders, STDs, unw
Letter/Video Statement to Ugandan Church Leaders: PRNewswire - December 10, 2009; -- By Dr. Rick Warren, Pastor of Saddleback Church, Lake Forest, Calif., Regarding the Pending Anti-Homosexuality Bill Before the Ugandan Parliament LAKE FOREST, Calif., Dec. 10 /PRNewswire/ -- Dear fellow pastors in Uganda, I greet you in the name and love of Jesus Christ as I send this encyclical video (http://www.yo
GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech: PRNewswire - December 10, 2009; ...it is also true that security does not exist where human beings do not have access to enough food, or clean water, or the medicine they need to survive. - President Barack Obama WASHINGTON, Dec. 10 /PRNewswire-USNewswire/ -- International Human Rights Day -- At his Nobel Peace Prize acceptance speech in Oslo,
Jesse Milan Jr. Steps Down as Black AIDS Institute Chair: PRNewswire - December 7, 2009; LOS ANGELES, Dec. 7 /PRNewswire-USNewswire/ -- Jesse Milan, Jr. steps down after seven years serving as Board Chairman for the Black AIDS Institute. Milan, replaced by incoming Chairman A. Cornelius Baker, will continue to serve on the Institute Board as Chair Emeritus. At a recent Board meeting, Institute Board Member
Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha: PRNewswire - December 5, 2009; CAPE TOWN, South Africa , December 5/PRNewswire/ -- The first Football for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors today (5 December 2009). FIFA President Joseph S. Blatter was joined by Western Cape Premier Helen Zille, 2010 FIFA World Cup Organising Committee South Africa (OC) CEO Da
Viral Genetics Licenses Immune Disease Therapeutic Platforms from University of Colorado: PRNewswire - December 3, 2009; COLORADO SPRINGS, Colo., Dec. 3 /PRNewswire-FirstCall/ -- The University of Colorado and Viral Genetics Inc., (Pink Sheets: VRAL) recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cance
LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer: PRNewswire - December 2, 2009; -- Fund expects profit and impact from reaching 50,000 HIV+ and diabetic clients JOHANNESBURG, Dec. 2 /PRNewswire/ -- LeapFrog Investments has announced a ZAR 50 million (over US$6 million) investment in AllLife, the innovative South African insurer serving people living with HIV and diabetes. The investment brings tog
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus: PRNewswire - December 2, 2009; -- cobas(R) TaqScreen MPX Test is the most comprehensive - detects multiple viruses for increased plasma product safety PLEASANTON, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food & Drug Administration ( FDA ) approved
Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures: PRNewswire - December 2, 2009; NEW YORK, Dec. 2 /PRNewswire-USNewswire/ -- Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting. FasterCures, the Washington-based center of the Milken Instit
South Africa / Speech by Gunilla Carlsson, Sweden's Minister for International Development Cooperation: PRNewswire - December 2, 2009; PRETORIA, December 2, 2009/African Press Organization (APO)/ -- Speech by Gunilla Carlsson commemorating World AIDS Day in Pretoria, South Africa : Mr President/ Mr Vice-President, Executive Director of UNAIDS , Judge Cameron, Ministers, Ambassadors, Colleagues and Friends, It is a great honour for me to celebrate
Universal Access to Care and Treatment should be a Basic Human Right: PRNewswire - December 1, 2009; ALEXANDRIA, Va., Dec. 1 /PRNewswire-USNewswire/ -- More than 33.4 million people are living with HIV/AIDS in the world today with 2.7 million new infections occurring each year. FHSSA reports, Sub-Saharan Africa is unequally impacted by HIV/AIDS, with 71% of new infections each year. December 1 is World AIDS Day, a day
Pelosi Statement in Recognition of World AIDS Day: PRNewswire - December 1, 2009; WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- House Speaker Nancy Pelosi issued the following statement today in recognition of World AIDS Day: On World AIDS Day, we remember, we reflect, and we recommit to ending HIV/AIDS. This year s theme -- Universal Access and Human Rights -- is a call to action, a sign of the con
Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day: Gay Men's Health Crisis Encourages People to 'Fight AIDS. Love Life.': PRNewswire - December 1, 2009; NEW YORK, Dec. 1 /PRNewswire-USNewswire/ -- Today on World AIDS Day, Gay Men s Health Crisis (GMHC) is reaffirming its commitment to continue helping diverse groups disproportionately affected by HIV and AIDS, including people struggling with crystal methamphetamine use. GMHC is announcing an innovative, interactive cr
GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress: PRNewswire - December 1, 2009; ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the Company ), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its support for World AIDS Day. Today is t
How to Help on World AIDS Day and Year-Round: Companies, Churches, and Community Groups Can Equip AIDS Caregivers With Kits: PRNewswire - December 1, 2009; -- Despite recession, American communities support AIDS-affected countries through World Vision SEATTLE, Dec. 1 /PRNewswire-USNewswire/ -- While many Americans are experiencing hardship, some communities and churches are remembering their relative abundance and reaching out to those affected by AIDS in the developing w
World AIDS Day / Improve Treatment Access for Kenyan Children: PRNewswire - December 1, 2009; NAIROBI, December 1, 2009/African Press Organization (APO)/ -- Providing universal access to HIV treatment for children remains a distant goal in Kenya , Human Rights Watch said today, World Aids Day. Over the last year, the number of HIV-infected children on antiretroviral treatment in Kenya has risen to about 28,000.
Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population: PRNewswire - December 1, 2009; WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- On December 31, 2008, a reported 20,606 state prisoners and 1,538 federal prisoners were HIV positive or had confirmed AIDS, the Bureau of Justice Statistics (BJS) in the Office of Justice Programs, U.S. Department of Justice, announced today. At yearend 2008, an estimated
Boehringer Ingelheim Launches MindBodyHAART.com, a Comprehensive Online Resource for the HIV/AIDS Community: PRNewswire - December 1, 2009; -- Web Site Offers Expert Videos, Downloadable Educational Information, Tips for Living a Healthier Life and Resources for Patient Assistance Programs RIDGEFIELD, Conn., Dec. 1 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the Mind, Body, HAART Web site (www.MindBodyHAART.com)
Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS: New Web site, www.TheGraceStudy.com, offers information for people living with HIV, healthcare professionals and treatment educators: PRNewswire - December 1, 2009; BRIDGEWATER, N.J., Dec. 1 /PRNewswire/ -- Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that it is launching a new initiative to raise awareness of issues affecting women and people of color living with HIV/AIDS. Through a comprehensive campaign including local educational e
TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements: PRNewswire - November 30, 2009; -- Sponsored by Merck, the unique online and mobile tool empowers patients to be active participants in their HIV treatment decisions ARLINGTON, Va., Nov. 30 /PRNewswire-USNewswire/ -- TheBody (www.thebody.com), the #1 HIV/AIDS resource online, today launched My Health Tracker, an online and mobile tool offering HIV/AI
Global AIDS Alliance: Background for 11/30/09 White House Announcement on Global HIV/AIDS: PRNewswire - November 30, 2009; Today, the White House is releasing its six-year strategy on HIV/AIDS. This event coincides with the World Health Organization s release earlier this morning of new antiretroviral treatment guidelines (ART) for HIV-positive individuals. Unless the White House dramatically increases its budget requests for global HIV/AI
USAID Recognizes World AIDS Day: From Acting Administrator Alonzo L. Fulgham: PRNewswire - November 30, 2009; WASHINGTON, Nov. 30 /PRNewswire-USNewswire/ -- On December 1, the global community once again recognizes World AIDS Day and the 33 million people living with HIV/AIDS worldwide. This is also a time to renew our commitment to work together to fight against this epidemic and pay homage to the millions of people who have
Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day: PRNewswire - November 30, 2009; -- Exclusive Interview Advisory for Tuesday, December 1, 2009 (World AIDS Day) WHO & WHY: The face of HIV and AIDS has changed over the past three decades. The disease, originally called Gay-related Immune Deficiency (GRID), is now on the rise among heterosexuals, women, African Americans, Latinos and men who have
GAA Calls on President Obama to Act on the Reality of AIDS: PRNewswire - November 30, 2009; This epidemic is far from over. Every year, almost three million people become infected with HIV, and two million die from AIDS-related diseases. WASHINGTON, Nov. 30 /PRNewswire-USNewswire/ -- On World AIDS Day 2009 the Global AIDS Alliance (GAA) calls on President Obama and his advisors to reflect on two recent alarm
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine): PRNewswire - November 25, 2009; BRIDGEWATER, N.J., Nov. 25 /PRNewswire/ -- The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 stra
New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS: PRNewswire - November 24, 2009; WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- America s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1
'China's Mother Teresa Exposes HIV/AIDS Epidemic to the World on AIDS Day': PRNewswire - November 24, 2009; -- Press Conference with Dr. Gao Yaojie, Author of China s AIDS Plague: 10,000 Letters, December 1, 2009 from 9:00 AM to 11:00 AM Hosted by Open Books and ChinaAid Bloomberg Room, National Press Club WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- Dr. Gao Yaojie s book China s AIDS Plague: 10,000 Letters was first publi
The Good, the Bad, and the Ugly for Consumer Protection in the U.S. Senate Health Reform: PRNewswire - November 23, 2009; -- Pre-emption of State Health Benefit Laws Is a Major Retreat; Insurance Rate Justification Shows Promise WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Consumer Watchdog released a list today of the 10 key positive and negative consumer protection provisions of the U.S. Senate health reform bill, HR 3590, which passe
Hollywood Comes to Washington, DC: Walk the Red Carpet for a Cause -- HIV/AIDS: PRNewswire - November 23, 2009; WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- The National Medical Association (NMA) in collaboration with award winning actor Egypt formerly Devin T. Robinson X of AIDS Awareness Poets, Inc., will host a free movie premier of God, Me... HIV? on the eve of World AIDS Day, November 30th at the Newseum, 555 Pennsylvania
Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December: Hoops Of Hope Kids To Shoot 15 Million Free Throws In 2010 World's Largest Free Throw Festival: PRNewswire - November 23, 2009; -- HOOPS OF HOPE FOUNDER PLANS 12-CITY U.S. TOUR & TRIP TO AFRICA NEXT YEAR WORLD VISION SUPPORTS YOUNG AUTHOR S NEW BOOK TAKE YOUR BEST SHOT SEATTLE, Nov. 23 /PRNewswire-USNewswire/ -- Next week, in an effort to fight the global spread of HIV/AIDS, thousands nationwide will take part in Hoops of Hope, the world s
Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure: PRNewswire - November 21, 2009; NEW YORK, Nov. 21 /PRNewswire/ -- Milvia Lopez, by her attorney MICHAEL STEWART FRANKEL, of New York City, recently filed suit, in Supreme Court, New York County, bearing Index # 112888/2009. The complaint alleges that while Ms. Lopez underwent a routine transesophageal echocardiogram ( TEE ) at ST. VINCENT S HOSPITAL,
Reversing the AIDS Epidemic Through Strengthened Health Systems: MSH Paper Calls for a New Way Forward for Third-Generation AIDS Programs: PRNewswire - November 19, 2009; CAMBRIDGE, Mass., Nov. 19 /PRNewswire-USNewswire/ -- Management Sciences for Health (MSH) calls for a dramatic change in strategy to focus on strengthening health systems in the countries most affected by HIV & AIDS. The call for concerted action is urgent: AIDS is the leading cause of death and disease among women
PROPER ATTIRE(R) & Keith Haring Foundation Take Action This World Aids Day to Prevent and Protect in a Hip and Innovative Way: PRNewswire - November 19, 2009; NEW YORK, Nov. 19 /PRNewswire/ -- PROPER ATTIRE® condoms and the Keith Haring Foundation will commemorate World AIDS Day with one of the most influential and socially responsible collaborations. Honoring World AIDS Day, Keith Haring for PROPER ATTIRE® condoms will premiere December 1, 2009, at the exclusive Mondrian in
Synergy Production Group Announces Hoops of Hope All-Stars Tour, the World's Largest Free Throw Festival, to Raise Money for AIDS Orphans in Africa: PRNewswire - November 19, 2009; -- Austin Gutwein, who founded Hoops of Hope at age nine, will host the 12-city series from April through August 2010 NASHVILLE, Tenn., Nov. 19 /PRNewswire-USNewswire/ -- Synergy Production Group today announced the 2010 launch of the Hoops of Hope All-Stars Tour to raise funds for projects benefiting AIDS orphans in A
Adamas Pharmaceuticals Expands Clinical Study for Triple-Combination Antiviral Drug Therapy in Immune-Compromised Patients: PRNewswire - November 19, 2009; EMERYVILLE, Calif., Nov. 19 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States ,
Teva Launches TevaGrastim(R) (Black Triangle Drug) (filgrastim): PRNewswire - November 18, 2009; Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-CSF* therapy area. The launch of its proprietary version of filgrastim, TevaGrastim(R), marks the Company s first biosimilar*, and represents a major addition to Teva s Hospitals portfolio. TevaGrastim(R) is licensed for a
Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference: PRNewswire - November 18, 2009; -- In Preclinical Studies, Peregrine s PS-Targeting Antibodies Including Bavituximab Demonstrated Broad Spectrum Binding to Viruses and Virally Infected Cells Representing Three Viral Hemorrhagic Fever (VHF) Families - - Preclinical Efficacy Studies Showed that a Single Dose of PS-Targeting Antibodies Increased the Sur
Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS: PRNewswire - November 18, 2009; RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo s zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were inadvertently and prematurely disclosed
Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries: PRNewswire - November 17, 2009; -- Zyomyx s innovative approach enters final phase to become the world s first low-cost, instrument-free test for measuring CD4 T-cell count in HIV/AIDS patients HAYWARD, Calif., Nov. 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care
(RED)(TM) Partners Including Starbucks, Gap and Dell Will Give More to Help Raise Awareness and Funds on World AIDS Day, December 1: PRNewswire - November 17, 2009; -- (RED) POP-UP SHOPS TO OPEN IN MAJOR CITIES ACROSS THE GLOBE, CREATING MORE WAYS TO GIVE (RED) THIS HOLIDAY SEASON NEW YORK, Nov. 17 /PRNewswire/ -- (RED) today announced that this World AIDS Day, December 1, 2009, partners including Starbucks Coffee Company, Gap and Dell will make special increased contributions thr
National Medical Association to Host T.E.A. Talk to Help Educate Women of Color on Living Healthier Lives: PRNewswire - November 17, 2009; -- Talk Show Format Program Encourages Women to Turn (Health) Education into Action WASHINGTON, Nov. 17 /PRNewswire-USNewswire/ -- The National Medical Association (NMA) along with the Southeast Dairy Association, the Auxiliary to the Columbus-Ft. Benning Medical Association, the Columbus Georgia Chapter, T
STD Programs Facing Severe Cutbacks, Affecting Public Health Infrastructure: Economic Crisis Impacting Health Department Capacity to Address Rising STD Rates: PRNewswire - November 16, 2009; WASHINGTON, Nov. 16 /PRNewswire-USNewswire/ -- Amid the mounting toll of budget cuts across the country, a new study from the National Coalition of STD Directors (NCSD) shows just how much an impact the economic crisis is having on sexually transmitted disease (STD) programs and in turn, having more broadly on public h
NYC's African Diaspora Community Welcomes the Second-Generation Female Condom (FC2): African Services Committee Applauds City for Its Efforts to Expand Access to Woman-Initiated HIV Prevention: PRNewswire - November 16, 2009; NEW YORK, Nov. 16 /PRNewswire-USNewswire/ -- African Services Committee is praising New York City s Department of Health, for showing national leadership in putting the second-generation female condom into the hands of women living with or at risk of HIV/AIDS infection. We enthusiastically endorse New York City s effor
At Least 87 Million Americans At Risk of Losing Health Protections Under U.S. Senate Finance Health Reform Bill: Finance Bill Expected To Preempt State Health Benefit Mandate Laws Such As HIV Testing, Reconstructive Surgery, Home Health Services: PRNewswire - November 16, 2009; WASHINGTON, Nov. 16 /PRNewswire-USNewswire/ -- Under the U.S. Senate Finance health reform bill, approximately 87 million Americans are at risk of being sold junk insurance that does not cover key treatments and health services like HIV testing, reconstructive surgery, and home health services, Consumer Watchdog wrote
Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient: PRNewswire - November 16, 2009; DALLAS, Nov. 16 /PRNewswire/ -- Methodist Dallas Medical Center recently made history when it became the first in the Dallas-Fort Worth Metroplex to perform a kidney transplant on an HIV positive patient. The patient, a 40-year old African American male, is healthy, well, and enjoying a life free from dialysis for the
New York City Introduces Second-Generation Female Condom; Less-Expensive FC2 Will Help City Expand Female Condom Access: PRNewswire - November 16, 2009; NEW YORK, Nov. 16 /PRNewswire-FirstCall/ -- New York City s Department of Health and Mental Hygiene (DOHMH) will soon distribute the Female Health Company s (FHC) (NASDAQ:FHCO) second-generation FC2 Female Condom®, which received approval for the U.S. market from the Food and Drug Administration ( FDA ) earl
South Africa / 5th SAHARA Conference: PRNewswire - November 13, 2009; MIDRAND, November 13, 2009/African Press Organization (APO)/ -- 5th SAHARA Conference, Gallagher Estate, Midrand, 30 November - 3 December 2009 The Social Aspects of HIV/AIDS Research Alliance (SAHARA), a research network within the Human Sciences Research Council (HSRC), wants to draw your attention to its 5th SAHARA
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference: PRNewswire - November 12, 2009; -- Favorable safety and pharmacokinetic data support further clinical development PRINCETON, N.J. and SAN DIEGO, Nov. 12 /PRNewswire/ -- Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, to
'Project Runway' Designer Launches New Video in Online Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma: PRNewswire - November 11, 2009; -- Jack Mackenroth interviews local Philadelphia HIV and AIDS advocates for Living Positive By Design: Creating Positive Conversations video series PHILADELPHIA, Nov. 11 /PRNewswire/ -- Today Jack Mackenroth, a fashion designer from the hit reality television series Project Runway, who has been living with HIV for more
Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2009: PRNewswire - November 11, 2009; KVISTGARD, Denmark , November 11/PRNewswire-FirstCall/ -- Today Bavarian Nordic published the company s third quarterly report 2009. The full report including the financial statements is available on the company s website: http://www.bavarian-nordic.com. In the first nine months of 2009 Bavarian Nordic generated re
Relief Group Says Simple, Effective Tactic in Global AIDS Fight Also One of Most Neglected: PRNewswire - November 10, 2009; -- New report shows prevention efforts still not priority in most poor countries health budgets -- Only 1 in 3 HIV-positive pregnant women gets treatment to prevent mother-to-child transmission -- World Vision s Not my HIV campaign for World AIDS Day presses for faster progress SEATTLE, Nov. 10 /PRNewswire-USNewswire/
CVS Caremark and Generation Health Form Strategic Partnership to Offer Personalized Medicine: PRNewswire - November 10, 2009; -- Integrated approach to pharmacogenomic medicine to improve patient outcomes and reduce cost WOONSOCKET, R.I. and UPPER SADDLE RIVER, N.J., Nov. 10 /PRNewswire/ -- CVS Caremark (NYSE:CVS), the nation s largest pharmacy health care provider, and Generation Health, Inc., a genetic benefit management company (GBM), toda
Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS: PRNewswire - November 9, 2009; WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement praising provisions in the Affordable Health Care for America Act (H.R. 3962) that will improve access to Medicaid and reduce Medicare Part D costs for people living with HIV/AIDS. H.R. 3962 passed the House on Saturday
Hollywood & Highland Center and One Heartland Present 'Holiday of Hope' Tree-Lighting Celebration and Benefit Saturday, November 28th: PRNewswire - November 9, 2009; Hannah Montana Star and Disney Recording Artist, MITCHEL MUSSO, Idol Finalists, KIMBERLEY LOCKE and MICHAEL JOHNS and I M OK YOU RE OK To Perform Tickets On Sale Now For Private Reception Benefitting ONE HEARTLAND HOLLYWOOD, Calif., Nov. 9 /PRNewswire/ -- What: Bringing families all over Los Angeles to the heart of Ho
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat: PRNewswire - November 6, 2009; WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem th
GenVec Signs New Contract to Support HIV and Influenza Vaccine Development: PRNewswire - November 5, 2009; GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAI
Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies: PRNewswire - November 4, 2009; -- Broad New Patent Covers Peregrine s Lead PS-Targeting Antibody Bavituximab and Similar Agents for the Treatment of All Viral Infections -- New Patent Covers Applications under Active Development Including HCV Clinical Program and R&D Activities in Viral Hemorrhagic Fever, HIV, CMV and Other
ViiV Healthcare Launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care: PRNewswire - November 3, 2009; CEO promises relentless pursuit of new treatments London UK, November 3, 2009 /PRNewswire/ -- Today, ViiV Healthcare, a new specialist HIV company established by GlaxoSmithKline (GSK) and Pfizer , was officially launched. Dr. Dominique Limet, the Chief Executive Officer of ViiV Healthcare, outlined the company s ethos
Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound: PRNewswire - November 3, 2009; SAN MARCOS, Texas, Nov. 3 /PRNewswire/ -- Texas State University and Orizon Research Institute announced the signing of an agreement today that will permit University Researchers to continue efforts through in vivo testing to further determine the potential and effectiveness of ALKA-V6, a compound which has shown remar
President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department: PRNewswire - November 3, 2009; -- Facility is First in Tanzania to Meet International Standards in Emergency Medicine; Effort is Latest Result of Longstanding Partnership to Strengthen Tanzania s Health Care System DAR ES SALAAM, Tanzania, Nov. 3 /PRNewswire/ -- For the first time, emergency room services meeting international standards will be a pa
Cambodia: World AIDS Day HIV Campaign, 'Testing Millions,' to Again Launch During Cambodia's National Water Festival: PRNewswire - October 31, 2009; -- During Last Year s One Million Tests World AIDS Day 2008 Campaign, AHF/ Cambodia CARES and Cambodian Partners Surpassed Country s 30,000 Testing Goal by Testing 35,034 PHNOM PENH, Cambodia, Oct. 31 /PRNewswire-USNewswire/ -- As part of an ambitious global effort to test several million people for HIV in observance o
'Project Runway' Designer Comes Full Circle to Educate About Living with HIV and Combat Stigma Associated with the Disease at United States Conference on AIDS: PRNewswire - October 31, 2009; -- Jack Mackenroth to bring Living Positive By Design campaign to San Francisco SAN FRANCISCO, Oct. 31 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is visiting San Francisco for the United States Conference on AIDS (USCA) and is bringing Living Positive By Design, his national
GAA Congratulates President Obama on New U.S. World Leadership in Lifting the HIV Travel Ban: PRNewswire - October 30, 2009; WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- The Global AIDS Alliance welcomes President Obama s announcement today to lift the 22 year-old U.S. travel and immigration ban on those living with HIV/AIDS. GAA Executive Director Paul Zeitz said We congratulate President Obama on his decision to end this unfounded and di
Pelosi: Ryan White Act Saves Lives and Offers a Lifeline of Treatment and Support to Americans Living With HIV/AIDS: PRNewswire - October 30, 2009; WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi issued the following statement today after attending a ceremony at the White House where President Obama signed the Ryan White HIV/AIDS Treatment Extension Act into law. Today s signing of the Ryan White HIV/AIDS Treatment Extension Act by President Ob
New Epidemic of Sexually Transmitted Hepatitis C Infection in HIV-infected Men in NYC: PRNewswire - October 30, 2009; -- Presentation: Sunday, November 1, 2009, 8:00 am Eastern Time in Boston, MA ALEXANDRIA, Va. and BOSTON, Oct. 30 /PRNewswire/ -- Researchers in New York City are reporting their work uncovering a new epidemic of hepatitis C virus (HCV) infection among men-who-have-sex-with-men (MSM) who have HIV infection. These autho
Texas State University Names Developer of ALKA-V6 Compound to Board of Advisors: PRNewswire - October 30, 2009; SAN MARCOS, Texas, Oct. 30 /PRNewswire/ -- The developer of a product, known as ALKA-V6, a proprietary modified silicon-based compound that is the subject of ongoing research as a potential cancer fighting weapon, has been named to the Committee of Advisors for the College of Applied Arts at Texas State University. Ig
DAI-Led Team Selected to Implement USAID Response to Emerging Infectious Diseases: PRNewswire - October 29, 2009; BETHESDA, Md., Oct. 29 /PRNewswire/ -- DAI has been awarded a five-year program aimed at preventing future pandemics such as HIV/AIDS and H1N1. The global infectious disease program, called RESPOND, funded at up to $185 million, is the largest of five U.S. Agency for International Development (USAID) projects designed
Black AIDS Institute Receives Long-Term Funding from CDC for African American HIV University (AAHU): PRNewswire - October 29, 2009; LOS ANGELES, Oct. 29 /PRNewswire-USNewswire/ -- Leaders from the Black AIDS Institute and the Centers for Disease Control and Prevention (CDC) met recently to finalize the details of a four and one-half year grant to fund the Institute s African American HIV University (AAHU) Community Mobilization College. The AAHU Co
Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS: PRNewswire - October 28, 2009; -- $14.5 million award to bring ZFP HIV therapy to the clinic RICHMOND, Calif. Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymph
Clinical Care Options Launches CCO HIV inPractice, a Unique, Free, Comprehensive Online Resource for Healthcare Providers at the Point of Care: PRNewswire - October 28, 2009; RESTON, Va., Oct. 28 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative online, print, and live medical education programs and medical education technologies for healthcare professionals, announced the launch of CCO HIV inPractice, a new, free, online point-of-care resourc
Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds: NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition: PRNewswire - October 28, 2009; CARY, N.C. and BIRMINGHAM, Ala., Oct. 28 /PRNewswire-USNewswire/ -- Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract research organization conducting basic and applied preclinical drug research, today announced that several bioact
Bill and Melinda Gates: Global Health is 'America's Best Investment for Saving Lives': In speech to policymakers, Gateses to call for global push to halve child deaths by 2025: PRNewswire - October 27, 2009; WASHINGTON, Oct. 27 /PRNewswire-USNewswire/ -- In a joint speech to policymakers tonight, Bill and Melinda Gates will make the case that U.S. initiatives to fight AIDS, malaria, and other diseases in poor countries are America s best investment for saving lives, and that continued support could help cut child deaths in
African American Office of Gay Concerns (AAOGC) To Launch 'Status Is Everything' HIV Testing Campaign: PRNewswire - October 27, 2009; -- Status Is Everything Social Marketing Campaign Targets Young African American Gay Men In Newark NEWARK, N.J., Oct. 27 /PRNewswire/ -- Beginning January 2010 in Newark, African American men who have sex with men will be targeted by an HIV Testing social marketing campaign titled Status Is Everything organized by the
Financial Times to Launch Special Report on 'Combating AIDS' With Contribution to Global Business Coalition: PRNewswire - October 27, 2009; NEW YORK, Oct. 27 /PRNewswire/ -- The Financial Times announces the launch of its special report Combating AIDS. The supplement will be distributed in all global editions of the FT on Tuesday 1st December 2009, to coincide with World AIDS Day. Following the success of the FT special report on Combating Malaria, publis
Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID: PRNewswire - October 26, 2009; -- Seattle and Ugandan researchers collaborate to study and treat infection-related cancers SEATTLE, Oct. 26 /PRNewswire/ -- Building on the strengths of two institutions separated by nearly 9,000 miles over two continents - both renowned in their work in the fight against cancer - the United States Agency for Inte
Growing Threat of Substandard and Counterfeit Medicines in Developing Countries Addressed by New USAID-USP Cooperative Agreement: PRNewswire - October 26, 2009; ROCKVILLE, Md., Oct. 26 /PRNewswire-USNewswire/ -- With substandard and counterfeit versions of medicines intended to treat life-threatening diseases such as malaria, HIV/AIDS and tuberculosis posing a growing threat throughout the developing world, the U.S. Agency for International Development (USAID) and the U.S. Pha
MTV Documentary Starring Hip Hop Artist Travis McCoy Explores His Life-changing Journey in Support of HIV/AIDS Campaign Staying Alive: PRNewswire - October 26, 2009; TRAVIS MCCOY S UNBEATEN TRACK TO PREMIERE ON MTV CHANNELS AROUND THE WORLD ON WORLD AIDS DAY, DECEMBER 1, 2009 MCCOY S CHARITY SINGLE ONE AT A TIME WILL BE AVAILABLE AS A DIGITAL DOWNLOAD ON ITUNES FROM DECEMBER 1, 2009 LONDON, Oct. 26 /PRNewswire/ -- Staying Alive, MTV Networks International s global HIV and AIDS pre
Nigel Barker Premieres Documentary Generation Free, Highlighting the Global Work of the Elizabeth Glaser Pediatric AIDS Foundation: PRNewswire - October 23, 2009; -- Film Chronicles Foundation s Twenty-Year Battle to Eradicate Pediatric AIDS and Create a Generation Free of HIV NEW YORK, Oct. 23 /PRNewswire-USNewswire/ -- Prominent photographer, television personality, and filmmaker Nigel Barker premiered his newest documentary film last evening, entitled Generation Free, about t
White House Staff to Meet With Northern California Community to Discuss U.S. National HIV/AIDS Strategy: PRNewswire - October 22, 2009; BERKELEY, Calif., Oct. 22 /PRNewswire-USNewswire/ -- Sunday, November 1, 2009 the White House Office of National AIDS Policy (ONAP) is hosting an open community discussion on the National HIV/AIDS Strategy (NHAS) at Berkeley High School. The forum is open to everyone interested in listening or sharing opinions related
Eazyrecruit to Support Starfish Greathearts through a Five Year Pledge: PRNewswire - October 21, 2009; LONDON, October 21/PRNewswire/ -- Eazyrecruit, the fixed fee resourcing firm, pledged to support Starfish, a leading HIV/AIDS charity in a five year donation deal. In 2001 a group of friends founded a charity in a London coffee shop that would in 2009 end up supporting 40,000 plus children who have been affected by HIV
USAID Launches Emerging Pandemic Threats Program: PRNewswire - October 21, 2009; WASHINGTON, Oct. 21 /PRNewswire-USNewswire/ -- The United States Agency for International Development (USAID) is launching an Emerging Pandemic Threats (EPT) program that builds on the successes of the Agency s long-standing programs in disease surveillance, training, and outbreak response, particularly those addressin
Pelosi Applauds House Passage of Ryan White HIV/AIDS Treatment Extension Act: PRNewswire - October 21, 2009; WASHINGTON,Oct. 21 /PRNewswire-USNewswire/ --Speaker Nancy Pelosi released the following statement in support of the Ryan White HIV/AIDS Treatment Extension Act, which passed the House of Representatives today by a vote of 408 to 9. The Senate passed the bill earlier this week so the bill now goes to President Obama fo
Supermodel and Actress Molly Sims Helps PSI Launch Youth Center in Haiti: PRNewswire - October 21, 2009; -- H&M provides the donation for the center that will help thousands of street children PORT-AU-PRINCE, Haiti , Oct. 21 /PRNewswire-USNewswire/ -- Internationally-renowned top model and actress Molly Sims today launched a new youth center for street children in Haiti s capital, Port-au-Prince. PSI (Population Servi
Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research: PRNewswire - October 20, 2009; PARIS, Oct. 20 /PRNewswire-USNewswire/ -- Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an investigational HIV vaccine regimen was safe and modestly effective at reducing the rate of HIV infection compared to placebo. These results wer
GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia: PRNewswire - October 20, 2009; ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ( GeoVax or the Company ), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it will move its corporat
Global Aids Alliance Voices Its Strong Support for the International Violence Against Women Act: PRNewswire - October 19, 2009; Violence against women and girls is both a cause and a consequence of HIV/AIDS. WASHINGTON, Oct. 19 /PRNewswire-USNewswire/ -- On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Righ
Intact America Urges Pediatricians to Say No to Infant Circumcision - The Baby, Not The Parent, Is Your Patient: PRNewswire - October 19, 2009; ISSUES OPEN LETTER CALLING ON ATTENDEES AT AMERICAN ACADEMY OF PEDIATRICS MEETING TO REJECT CALL TO RECOMMEND IN FAVOR OF CIRCUMCISION FOR FIRST TIME UNNECESSARY, RISKY SURGERY FAILS TESTS OF MEDICAL ETHICS AND HUMAN RIGHTS WASHINGTON, Oct. 19 /PRNewswire-USNewswire/ -- Leaders of Intact America (www.intactamerica.org)
'Project Runway' Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design: PRNewswire - October 18, 2009; Jack Mackenroth partners with Merck & Co. , Inc. to combat stigma of HIV PHILADELPHIA, Oct. 18 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is visiting Philadelphia for this year s annual AIDS Walk Philly and is bringing Living Positive By Design, a national HIV and AIDS e
Uganda / 'Anti-Homosexuality' Bill Threatens Liberties and Human Rights Defenders Proposed Provisions Illegal, Ominous, and Unnecessary: PRNewswire - October 16, 2009; KAMPALA, October 16, 2009/African Press Organization (APO)/ -- The draft Anti-Homosexuality Bill introduced on October 14, 2009 in Uganda s parliament would violate human rights and should be withdrawn immediately, a group of 17 local and international human rights organizations said today. This bill is a blow to the p
One Heartland Hosting: S'more to Love Cocktail Fundraiser: Improving the lives of children and families impacted by HIV/AIDS: PRNewswire - October 15, 2009; NEW YORK, Oct. 15 /PRNewswire/ -- One Heartland will host S more to Love , a cocktail fundraiser on Friday, November 6, 2009 at 7:30 P.M. at Open House Lofts, NYC to benefit Birch Family Camp. Celebrating its 20th year, the Birch Family Camp brings together 90 families (over 200 family members) from the 5 boroughs of N
Huge Protest of 'Faggots Have to Die' Singer Buju Banton at Cabana Club in Hollywood TONIGHT, Oct. 15: PRNewswire - October 15, 2009; LOS ANGELES, Oct. 15 /PRNewswire-USNewswire/ -- The L.A. Gay & Lesbian Center is organizing a huge protest tonight (Oct. 15) at the Cabana Club in Hollywood (1439 Ivar Ave.) at 8:30 p.m. against Buju Banton, a reggae singer who is notorious for a song that glorifies the brutal murder of gay and lesbian people. The
NeuroAIDS is Target of Federal Grant to Children's Hospital: PRNewswire - October 15, 2009; Novel HIV Drug to be Studied in Cell Cultures and in Patients PHILADELPHIA, Oct. 15 /PRNewswire-USNewswire/ -- A $6 million, five-year federal grant to The Children s Hospital of Philadelphia Research Institute will enable researchers to investigate a novel approach in treating HIV infection -- a unique class of drugs
Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community: PRNewswire - October 15, 2009; BRIDGEWATER, N.J., Oct. 15 /PRNewswire/ -- In support of National Latino AIDS Awareness Day, Tibotec Therapeutics is launching a new initiative to expand its commitment to raising awareness of HIV/AIDS issues in the Latino community. The company is sharing findings from the GRACE (Gender, Race And Clinical Experience)
Univision and Kaiser Foundation Mark National Latino AIDS Awareness Day With New Campaign Featuring People Living With HIV/AIDS: PRNewswire - October 15, 2009; -- Testimonials Aim to Inspire Hope and Debunk Myths in Response to Latino AIDS Crisis LOS ANGELES, Oct. 15 /PRNewswire-USNewswire/ -- Univision Communications Inc. and the Kaiser Family Foundation today unveiled the second phase of SOY. . . (I AM. . .), the groundbreaking Spanish-language media campaign featuring the
Statement from Dr. Howard Koh, Assistant Secretary for Health, U.S. Department of Health and Human Services, Regarding National Latino AIDS Awareness Day: PRNewswire - October 15, 2009; WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- United We Can Stop HIV and Prevent AIDS. Unidos Podemos Detener el VIH y Prevenir el SIDA. That is the message for the seventh annual National Latino AIDS Awareness Day, which our nation observes today, October 15. This day is an opportunity for us to honor the dedicated f
Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program': PRNewswire - October 15, 2009; ATLANTA, Oct. 15 /PRNewswire-FirstCall/ -- Today, Formatech, Inc. announced that GeoVax Labs, Inc. s (OTC Bulletin Board: GOVX) ( GeoVax ) ( Company ) HIV/AIDS vaccine will be the first clinical candidate that is formulated and filled under its Fillanthropy Program. The production run is scheduled to be completed in Ja
Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System: PRNewswire - October 14, 2009; -- Results Available in Less Than 50 Minutes, Helping Laboratories Improve Staff Efficiency and Increase Productivity RARITAN, N.J., Oct. 14 /PRNewswire/ -- Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration ( FDA ) approval of a diagnostic assay for the detection of antibodies to human immuno
Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System - Results Available in Less Than 50 Minutes, Helping Laboratories Improve Staff Efficiency and Increase Productivity: PRNewswire - October 14, 2009; RARITAN, N.J., Oct. 14 /PRNewswire/ -- Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration ( FDA ) approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2) for use on the VITROS(R) 5600 Integrated and VITROS(R) 3600 Immunodiag
Study Challenges Importance of Animals in Research: PRNewswire - October 13, 2009; BOSTON, Oct. 13 /PRNewswire-USNewswire/ -- A recently released paper published in the journal Alternatives to Laboratory Animals (ATLA 37, 399-416), presents a serious challenge to long-standing claims that animals are an important part of human cancer research. An Examination of Chimpanzee Use in Human Cancer Research
USAID Awards Five-Year Grant, Strengthening Health Outcomes through Private Sector (SHOPS): PRNewswire - October 9, 2009; WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- The United States Agency for International Development (USAID) has awarded a five-year grant, Strengthening Health Outcomes through the Private Sector, to Abt Associates, Inc. Sub-recipients under the grant are Banyan Global, Jhpiego, Marie Stopes International, the Monitor
Tennis Star Anna Kournikova Calls for Action to Protect Health of Russian Youth: PRNewswire - October 8, 2009; -- PSI leads Kournikova through a four-city tour of HIV prevention programs in Russia MOSCOW, Oct. 8 /PRNewswire-USNewswire/ -- Tennis star and PSI (Population Services International) Ambassador Anna Kournikova joined the government of Russia today calling for a coordinated response to the serious health issues facing
Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations: PRNewswire - October 7, 2009; -- New Anti-Viral Research Group to Coordinate and Expand Externally Funded Collaborations Assessing Peregrine s Broad-Spectrum PS-Targeting Antibodies as Potential Anti-Infective Therapies, Vaccines and Topical Preventatives - - Peregrine s PS-Targeting Anti-Viral Platform Is Being Studied at More than a Dozen Leading
Abt Associates to Conduct Demonstration Initiative for Federal Office of HIV/AIDS Policy Aimed At HIV Prevention Among Minority Youth: PRNewswire - October 5, 2009; $3.2 Million Demonstration Initiative Will Assist Minority Serving Institutions in Promotion of HIV Awareness, Testing and Prevention, and Responsible Sexual Health CAMBRIDGE, Mass., Oct. 5 /PRNewswire-USNewswire/ -- Abt Associates was awarded a $3.2 million contract by the U.S. Department of Health and Human Services
100th HIV/AIDS Drug Authorized in Association with PEPFAR: PRNewswire - October 5, 2009; WHAT: Ceremony marking the collaborative efforts in attaining the 100th Presidents Emergency Plan For AIDS Relief (PEPFAR) approved drug WHO: -- Margaret A. Hamburg, M.D. Commissioner of Food and Drugs -- Dr. Mirta Roses Periago, Director of the Pan American Health Organization, Regional Office of the
Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor: PRNewswire - October 1, 2009; -- Company Makes Announcement at a Meeting of Southeastern Reproductive Health Organizations FHC Makes Special Commitment to Expand Access in U.S. Regions with Highest AIDS Case Rates CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- The Female Health Company (FHC) (NASDAQ:FHCO) announced today that its second-generation FC2 F
USAID, General Mills, and PEPFAR Partner to Improve Food Processing in Africa: PRNewswire - September 28, 2009; NEW YORK, Sept. 28 /PRNewswire-USNewswire/ -- On Friday, a public-private partnership with General Mills, a leading U.S. food company, the U.S. Agency for International Development (USAID) and the U.S. President s Emergency Plan for AIDS Relief (PEPFAR) was announced at the closing of the Fifth Annual Meeting of the Cl
WHO provides primary status to the Pan African Clinical Trials Registry: PRNewswire - September 25, 2009; CAPE-TOWN, Sep 25/African Press Organization (APO)/ -- The Pan-African Clinical Trials Registry (PACTR) has been accepted as a primary clinical trials registry - the first World Health Organization (WHO) endorsed trials registry in Africa. This registry will feed data into the global WHO International Clinical Trials R
Statement from Dr. Howard Koh, Assistant Secretary of Health, U.S. Department of Health and Human Services, Regarding National Gay Men's HIV/AIDS Awareness Day -- September 27, 2009: PRNewswire - September 25, 2009; WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ -- On September 27, our nation will observe National Gay Men s HIV/AIDS Awareness Day (NGMHAAD). This is a day for us to reflect on the devastating impact that HIV and AIDS have had among gay and bisexual men, to recognize that HIV continues to affect this community dispropo
VaxGen Congratulates HIV Prime-Boost Vaccine Study Collaborators and Clarifies Commercial Rights: PRNewswire - September 25, 2009; SOUTH SAN FRANCISCO, Calif., Sept. 25 /PRNewswire-FirstCall/ -- VaxGen , Inc. (BULLETIN BOARD: VXGN) today congratulated the Thai Ministry of Health, the U.S. Army, Sanofi Pasteur and VaxGen s licensee Global Solutions for Infectious Disease (GSID) on the encouraging results demonstrated in the RV144 clinical trial. T
New Initiative to Address Sexual Violence Against Girls Launched at Clinton Global Initiative Annual Meeting in New York: PRNewswire - September 25, 2009; -- Collaboration Among Leading Public and Private Sector Organizations Formed to Bring International Attention to this Injustice NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- The Centers for Disease Control and Prevention (CDC), five United Nations organizations (UNICEF, UNAIDS , UNFPA, UNIFEM, WHO) and private sector
PSI Commits to Expanding HIV Prevention at Clinton Global Initiative: Will also expand safe water programs with P&G's Children's Safe Drinking Water: PRNewswire - September 24, 2009; PSI (Population Services International) announced two significant commitments today at the Clinton Global Initiative (CGI): a doubling of its HIV prevention programs that target at-risk men and, in partnership with Procter & Gamble s Children s Safe Drinking Water program, a commitment that will expand the availabi
Gates Foundation Launches Campaign to Highlight Success of U.S. Global Health Investments: PRNewswire - September 24, 2009; SEATTLE, Sept. 24 /PRNewswire-USNewswire/ -- The Bill & Melinda Gates Foundation today launched the Living Proof Project: U.S. Investments in Global Health are Working, a multi-year awareness campaign to highlight the extraordinary success of the U.S. government s efforts to improve health around the world. The Liv
GenVec Receives Fourth-Year Funding From NIAID For HIV Vaccine Contract: PRNewswire - September 24, 2009; GAITHERSBURG, Md., Sept. 24 /PRNewswire-FirstCall/ -- GenVec, Inc. (NASDAQ:GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its third option period (year four) under a previously announced, five-year contract with
HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV: PRNewswire - September 24, 2009; ROCKVILLE, Md., Sept. 24 /PRNewswire/ -- A Phase III clinical trial involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection. According to final results released by the trial sponsor, the U.S. Army Su
AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study: PRNewswire - September 24, 2009; NEW YORK, Sept. 24 /PRNewswire-USNewswire/ -- Today marks an historic milestone in the search for an AIDS vaccine; we now have evidence that it is possible to reduce the risk of HIV infection with a vaccine, said AVAC executive director Mitchell Warren, reacting to the results of the first AIDS vaccine trial to ever sh
Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy: PRNewsire - September 24, 2009; ATLANTA, Sept. 24 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the Company ), an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), was pleased to hear the announcement today of partial success in the recently completed Phase
Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS: PRNewswire - September 23, 2009; -- Expansion of Program Will Test Repeat Dosing Protocol of SB-728-T RICHMOND, Calif., Sept. 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that the US Food and Drug Administration ( FDA ) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-l
Millennium Foundation Announces MASSIVEGOOD: Solidarity Movement to Help Finance Health Care for World's Poor: PRNewswire - September 23, 2009; NEW YORK, Sept. 23 /PRNewswire/ -- The Millennium Foundation for Innovative Finance for Health today announced MASSIVEGOOD, a new, innovative travel-related fundraising initiative that will help finance health care for the world s poor. During a high level meeting at the United Nations, leading representatives of the g
Santa Monica Votes to Draft Ordinance On City-Wide Cat De-Claw Ban: PRNewswire - September 23, 2009; SANTA MONICA, Calif., Sept. 23 /PRNewswire-USNewswire/ -- In a 5-1 vote, Santa Monica City Council passed a motion Tuesday to draft an ordinance that restricts the practice of amputating the toes of animals, also known as de-clawing. The motion was brought by City Council Members Kevin McKeown and Gleam Davis, who requ
US Patent Grant Extends VivaGel(R) Coverage to 2024: PRNewswire - September 22, 2009; MELBOURNE, Australia , Sept. 22 /PRNewswire/ -- Starpharma Holdings Limited today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect against sexually transmitted infections (STIs). The granting of this patent means that any product p
GeoVax Labs Requests pre-IND Meeting With FDA: Protocol Submitted for Phase 1 Therapeutic HIV/AIDS Vaccine Trial: PRNewswire - September 21, 2009; ATLANTA, Sept. 21 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the Company ), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigatio
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2: New Test Completes the ABBOTT PRISM Hepatitis and Retrovirus Panel: PRNewswire - September 21, 2009; ABBOTT PARK, Ill., Sept. 21 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) announced today it received approval from the U.S. Food and Drug Administration ( FDA ) for its ABBOTT PRISM HIV O Plus test, the first fully automated blood screening test for HIV-1/HIV-2. This test can be used by laboratory professionals to scree
FDA Approves Donor Screening Test for Antibodies to HIV: PRNewswire - September 18, 2009; SILVER SPRING, Md., Sept. 18 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism Syst
Are Obama Administration Policies Undermining Global AIDS and Health Responses?: PRNewswire - September 17, 2009; Alarming comments by new U.S. Global AIDS Coordinator, Ambassador Eric Goosby, may offer clues WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Later today, Ambassador Eric Goosby will be sworn in as the U.S. Global AIDS Coordinator. While we welcome Ambassador Goosby to his new post, and look forward to working with hi
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets: PRNewswire - September 16, 2009; PITTSBURGH, Sept. 16 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration ( FDA ) under the President s Emergency Plan for AIDS Relief (PEPFAR) for its New Drug
Tobira Therapeutics Inc. Announces Phase I Pharmacokinetic Data of TBR-652 for the Treatment of HIV: Multiple-doses up to 200 mg once-daily well tolerated: PRNewswire - September 14, 2009; PRINCETON, N.J. and SAN DIEGO, Sept. 14 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-
Strativa Pharmaceuticals' Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis: PRNewswire - September 14, 2009; -- Results Showcased at 49th Annual ICAAC Meeting WOODCLIFF LAKE, N.J., Sept. 14 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE:PRX), today announced that its development partner BioAlliance Pharma SA presented Phase III study results fo
Antiviral Activity of S/GSK1265744, a Once-Daily, Unboosted Integrase Inhibitor in Clinical Development, Evaluated in Phase 1-2a Study in Healthy and HIV-Infected Subjects: PRNewswire - September 14, 2009; SAN FRANCISCO, Sept. 14 /PRNewswire/ -- Shionogi- GlaxoSmithKline Pharmaceuticals, LLC announced today results from a Phase 1-2a study evaluating the pharmacokinetics (PK), safety and antiviral activity of its investigational integrase inhibitor (INI) S/GSK1265744 in healthy subjects and HIV-infected patients. The data
Center for AIDS Research at Emory University to Serve as Local Host of AIDS Vaccine 2010: PRNewswire - September 14, 2009; Atlanta to Serve as Stage for Premier Discussion on HIV Vaccine Development NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the
Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients: PRNewswire - September 14, 2009; -- VICTOR-E1 Study Results Sustained through 96 Weeks; Data Presented at ICAAC Annual Meeting SAN FRANCISCO, Sept. 14 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported long-term data with vicriviroc, its investigational CCR5 receptor antagonist, from an ongoing, open-label extension of the
Latino HIV/AIDS Crisis Demands Attention - Health Care Professionals from Across the United States Gather in New York City for National Conference on Latinos and AIDS to Address Concerns: PRNewswire - September 14, 2009; NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- To educate healthcare professionals on how to improve the Latino community s access to HIV/AIDS treatment and care, Minority Health Care Communications (MHCC) will hold the National Conference on Latinos and AIDS, September 14-15th, 2009, at the New York Academy of Medicine
Abbott Receives European Approval for Once-Daily Dosing of Kaletra(R) (lopinavir/ritonavir) Tablet: PRNewswire - September 14, 2009; -- New Approval Expands Dosing Options for Adult HIV-Infected Patients New to Antiretroviral Therapy ABBOTT PARK, Illinois, September 14/PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has received marketing authorization from the European Commission for once-daily dosing of the
Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV: Synergy with commonly used HIV therapies observed: PRNewswire - September 13, 2009; PRINCETON, N.J. and SAN DIEGO, Sept. 13 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combinati
Most Pharmaceutical Companies Receive Poor Grades on HIV/AIDS Drug Development Innovation, According to AIDS Treatment Activist Coalition Report Card: PRNewswire - September 10, 2009; -- Many Companies Get Low Marks in Five Benchmark Treatment Categories; New Drugs Need to Reflect Long-Term Care Strategy NEW YORK, Sept. 10 /PRNewswire/ -- With the estimated 1.2 million people with HIV/AIDS in the United States expected to live close to a normal life span, the majority of pharmaceutical companies are
Global Child Mortality Continues to Drop: UNICEF and UN Inter-Agency Panel Release New Figures: PRNewswire - September 10, 2009; NEW YORK, Sept. 10 /PRNewswire-USNewswire/ -- UNICEF today released new figures that show the rate of deaths of children under five years of age continued to decline in 2008. The data shows a 28 percent decline in the under-five mortality rate, from 90 deaths per 1000 live births in 1990, to 65 deaths per 1000 live bir
Video: Home-Spun or Hard Fact?: Fast-food family planning may contribute to high levels of unintended pregnancies: PRNewswire - September 10, 2009; NEWBURY, Berkshire, Sept. 10 /PRNewswire/ -- Women s health experts are warning that old wives tales and ignorance about modern contraceptive options could be fuelling Britain s high levels of unintended pregnancy, following new research into contraception myths by pollster Opinion Health.(1) To view the Multimedia New
SEIU Local 721 Calls for Attorney General to Investigate Self-Dealing and $22 Million in Extra Costs at Tarzana Treatment Center: PRNewswire - September 9, 2009; A Center for Public Accountability report submitted today to state Attorney General Jerry Brown details a pattern of financial abuses at Tarzana Treatment Center LOS ANGELES, Sept. 9 /PRNewswire-USNewswire/ -- SEIU Local 721 submitted an investigative report to the office of Attorney General Jerry Brown today providing
ARUP Laboratories' Scientist Tanya Sandrock Receives NIH Grant to Search for Additional HIV Therapies: PRNewswire - September 9, 2009; SALT LAKE CITY, Sept. 9 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced that ARUP s Tanya Sandrock, PhD, Research & Development scientist, received a prestigious National Institutes of Health
'Go and Good Things Happen' with (BUGABOO)(RED): Bugaboo announces partnership with (RED): PRNewswire - September 9, 2009; HERMOSA BEACH, Calif., Sept. 9 /PRNewswire/ -- Bugaboo is joining forces with (RED) to empower parents across the globe to participate in the fight against AIDS in Africa. Bugaboo, a modern mobility company, is encouraging parents to GO ... go outside, go discover, go experience. Through the new partnership with (RED),
Americans to Remember 9/11 With Acts of Service: Projects in All 50 States Mark First Time 9/11 Will Be Officially Recognized as a National Day of Service and Remembrance: PRNewswire - September 8, 2009; WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -- Americans across the country will honor the victims and heroes of the 9/11 tragedy by serving their neighbors and communities as part of the first-ever federally recognized September 11 National Day of Service and Remembrance. Service projects marking the eight-year annive
MTV Brings the Music to the Masses for VMA Weekend 2009: PRNewswire - September 3, 2009; -- 30H!3, Fefe Dobson, Cobra Starship, Phoenix and Kid Cudi Set To Perform in NYC NEW YORK, Sept. 3 /PRNewswire/ -- MTV is warming NYC up for the 2009 MTV Video Music Awards, which will air live from Radio City Music Hall on Sunday, September 13th at 9pm ET/PT, with a trio of music-filled events that will culminate wit
Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma: PRNewswire - September 1, 2009; -- Jack Mackenroth interviews local HIV and AIDS advocates for first Living Positive By Design: Creating Positive Conversations video series CHICAGO, Sept. 1 /PRNewswire/ -- Today Jack Mackenroth, from the hit reality television series Project Runway, launched a new online video series, called Living Positive By Design
SunGard Availability Services' Responsible Computing Project Powers Worldwide Volunteer Research: PRNewswire - August 31, 2009; -- More Than 1,000 SunGard Workstations Now Tapped to Power Scientific and Humanitarian Research Projects WAYNE, Pa., Aug. 31 /PRNewswire/ -- Demonstrating an aggressive commitment to sustainability and green technology practices, SunGard Availability Services has created the Responsible Computing Project, a project de
President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon: PRNewswire - August 27, 2009; -- Former President Will Address Issues of HIV/AIDS and Homelessness CHICAGO, Aug. 27 /PRNewswire-USNewswire/ -- Chicago House & Social Service Agency, the first organization in the Midwest to provide housing and support for people living with HIV and AIDS, will host their first ever Speaker Series Luncheon on Nove
Cote d'Ivoire / UNOCI helps fight STI and HIV/AIDS in Man prison: PRNewswire - August 25, 2009; ABIDJAN, August 25, 2009/African Press Organization (APO)/ -- The United Nations Operation in Cote d Ivoire , on 19 August 2009, organised training session to sensitize prisoners and staff at Man prison on sexually transmitted infections (STI) and HIV/AIDS. UNOCI initiated the training to provide prisoners with informa
Confidential Online STD Testing Clinic, getSTDtested.com, Introduces 'Edu-Tainment' for STD Prevention as Social Networking Changes Dating Scene: PRNewswire - August 25, 2009; -- Avatars educate young adults while tech savvy methods entertain them CHICAGO and CAMBRIDGE, Mass., Aug. 25 /PRNewswire/ -- getSTDtested.com, the industry s first online confidential clinic to use Web 2.0 technology that exclusively focuses on the awareness, testing and destigmitization of sexually transmitted diseas
Schwarzenegger's Budget Cuts Force Closure of California AIDS Clearinghouse: Clearinghouse Served Hundreds of Community-Based Health Organizations Throughout California: PRNewswire - August 25, 2009; LOS ANGELES, Aug. 25 /PRNewswire-USNewswire/ -- A casualty of California Governor Arnold Schwarzenegger s draconian cuts in social service funding, the California AIDS Clearinghouse will close next week. The L.A. Gay & Lesbian Center, which operated the program for more than 15 years, received notification from the
Miss Universe Contestants Enter Condom Olympics to Tackle HIV: Global health organization PSI helps contestants spread HIV prevention messages throughout the world: PRNewswire - August 21, 2009; NASSAU, Bahamas , Aug. 21 /PRNewswire-USNewswire/ -- The Miss Universe contestants continued preparations for Sunday night s pageant by competing today in the Condom Olympics - tossing water-filled condoms to test their strength and playing Wild Fire Infection games that demonstrate the serious side of HIV infection.
HerbalScience Research Demonstrates that HIV Infection Is Inhibited by Elderberry, Cinnamon, and Green Tea Extracts: Article Published in Antiviral Chemistry & Chemotherapy Identifies Specific Bioactive Compounds in Botanical Extracts that Block HIV Type-1 Infection in Vitro: PRNewswire - August 20, 2009; NAPLES, Fla., Aug. 20 /PRNewswire/ -- The development of new antiviral drugs has had a tremendous impact on the quality of life and life expectancy of HIV-positive and AIDS patients, as the drugs effectively disrupt the replication cycle of the HIV virus. Yet the regular use of those drugs - such as zidovudine (also kn
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment: PRNewswire - August 18, 2009; PITTSBURGH, Aug. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories, an Indian company in which Mylan owns a controlling stake, has received tentative approval from the U.S. Food and Drug Administration ( FDA ) under the President s Emergency Plan for AIDS Relief (PEPFAR) for
Shionogi-GlaxoSmithKline Pharmaceuticals Acknowledges Position of the European AIDS Treatment Group and the AIDS Treatment Activists Coalition to Revise Protocol for ING112276, a Clinical Study for S/GSK1349572: PRNewswire - August 13, 2009; LONDON, BRUSSELS, and NEW YORK, Aug. 13 /PRNewswire/ -- Shionogi- GlaxoSmithKline Pharmaceuticals, LLC, in collaboration with the European AIDS Treatment Group (EATG) and the Drug Development Committee (DDC) of the AIDS Treatment Activists Coalition (ATAC), today announces plans to revise inclusion criteria for Study I
BD and PEPFAR Collaboration Will Improve Blood-Drawing Practices in Hospitals and Clinics in Sub-Saharan Africa: PRNewswire - August 11, 2009; -- Blood Collection Safety Protects Patients And Health Workers FRANKLIN LAKES, N.J., Aug. 11 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President s Emergency Plan for AIDS Relief (PEPFAR) today announced a joint initiative to help protect health worker
HIV-Treating Clinicians Support Health Care Reform, Express Caution: Increased caseloads, lack of proper reimbursement, possibility of rationing HIV care cited as concerns: PRNewswire - August 10, 2009; WASHINGTON, Aug. 10 /PRNewswire-USNewswire/ -- The International Association of Physicians in AIDS Care (IAPAC), which represents approximately 4,000 HIV-treating clinicians in the United States [out of a global membership of over 13,000], today released results of a nationwide survey indicating that while supportive o
Gazelle Launches Technology for Tots Fundraising Campaign with SHARED, Inc.: Innovative Online Donation Platform To Raise Money for Orphans in Lesotho: PRNewswire - August 10, 2009; BOSTON, Aug. 10 /PRNewswire/ -- In an effort to improve the lives of orphans with AIDS who reside in Lesotho , Africa, SHARED, Inc., a not-for-profit organization dedicated to improving global health by increasing access for the world s poorest people to medicine, medical supplies, medical equipment and community garde
Major Biotechnology Company Selects OmniComm Systems to Provide eClinical Solutions for Phase I HIV Trials: PRNewswire - August 10, 2009; FT. LAUDERDALE, Fla., Aug. 10 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (BULLETIN BOARD: OMCM) , a global leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a major West coast biopharmaceutical company has selected OmniComm to provide eClinical solutions for two
President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries: PRNewswire - August 6, 2009; -- Second-line HIV/AIDS treatment available from Matrix, a Mylan company, at $475 today and at $425 in 2010, 28% lower than the current lowest-priced alternative PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ -- President Bill Clinton, Mylan Chairman and CEO Robert J. Coury and Matrix Laboratories Founder and Vice Chairman
GeoVax Labs, Inc. Provides Clinical Studies Update: PRNewswire - August 5, 2009; ATLANTA, Aug. 5 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, today announced updates on its ongoing and planned human clinical trials. We have two main areas of focus for our HIV/AIDS vaccine - preventative and therapeutic, stated Robert
State Regulation of Massage Therapy Will Improve Public Health, Safety: PRNewswire - August 5, 2009; HARRISBURG, Pa., Aug. 5 /PRNewswire-USNewswire/ -- At its initial meeting today, the State Board of Massage Therapy began drafting preliminary regulations that will protect the health and safety of residents, said Secretary of the Commonwealth Pedro A. Cortes. By requiring massage therapists in Pennsylvania to obtain p
VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration: PRNewswire - August 4, 2009; MELBOURNE, Australia , Aug. 4 /PRNewswire-FirstCall/ -- Starpharma Holdings Limited today announced the results of its clinical trial demonstrating that VivaGel retains antiviral activity against human immunodeficiency virus (HIV) and herpes simplex virus (HSV, the virus that causes
Scientists Discover Origin of Malaria: PRNewswire - August 3, 2009; -- Discovery Could Lead to Development of New Treatments, Prevent Future Plagues SAN FRANCISCO, Aug. 3 /PRNewswire-USNewswire/ -- Today scientists reported that they have discovered the origin of malaria, one of the deadliest diseases of humanity. Chimpanzees, native to equatorial Africa, have been identified as the or
GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip: PRNewswire - July 31, 2009; WASHINGTON, July 31 /PRNewswire-USNewswire/ -- Global AIDS Alliance executive director Dr. Paul Zeitz issued the following statement today on the eve of Secretary of State Hillary Clinton s departure for a seven-nation tour of Africa: We applaud Secretary Clinton s decision to visit Africa next week and her decision to
Statement By Dr. Paul Zeitz Regarding a Proposed Amendment By Rep. Mark Souder to Prohibit HHS Funding For Needle Exchange: PRNewswire - July 24, 2009; WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Yesterday, the U.S. House of Representatives Rules Committee approved an amendment by Representative Mark Souder (R-IN) which prohibits HHS (Health and Human Services) funding for programs which distribute sterile needles or syringes to prevent the spread of blood-borne pa
Los Angeles County Launches Its Most Comprehensive Campaign Ever to Encourage HIV Testing: PRNewswire - July 23, 2009; -- Up to 70 percent of new HIV infections are spread by those who do not know they have HIV LOS ANGELES, July 23 /PRNewswire/ -- This week the Los Angeles County, Department of Public Health s Office of AIDS Programs and Policy is launching its most comprehensive community outreach campaign ever to encourage HIV testin
Abbott HIV Test Demonstrates Earlier Disease Detection: PRNewswire - July 22, 2009; CHICAGO, July 22 /PRNewswire-FirstCall/ -- Research presented today at the American Association for Clinical Chemistry annual meeting shows that an assay developed by Abbott for simultaneous detection of both HIV antigens and antibodies reduced the detection window by zero to nine days in this study compared to HIV ant
Tobira Therapeutics Inc. Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK-652 for the Treatment of HIV: PRNewswire - July 22, 2009; -- Long serum half-life allows for once-daily dosing PRINCETON, N.J. and SAN DIEGO, July 22 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacoki
Pre-chewed Food Could Transmit HIV: PRNewswire - July 21, 2009; -- First three cases of likely HIV transmission to infants via pre-chewed food suggest cautioning HIV-positive caregivers against pre-chewing food; also a need for more data MEMPHIS, Tenn., July 21 /PRNewswire-USNewswire/ -- Researchers have uncovered the first cases in which HIV almost certainly was transmitted from m
FDA Approves VITROS(R) Anti-HCV Assay for Use On VITROS 5600(R) Integrated and VITROS 3600(R) Immunodiagnostic Systems: Anti-HCV Testing Consolidated With Other Routine Assays: PRNewswire - July 21, 2009; RARITAN, N.J., July 21 /PRNewswire/ -- Ortho Clinical Diagnostics today announced the U.S. Food and Drug Administration ( FDA ) approval of the VITROS Anti-HCV assay for use on the VITROS 5600 Integrated and 3600 Immunodiagnostic Systems. This approval marks a major milestone in the successful launches of Ortho Clinica
JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community: PRNewswire - July 21, 2009; -- Project SHALEM: Partnering with the Faith-Based Community to Test in a Safe Place BALTIMORE, July 21 /PRNewswire-USNewswire/ -- Today, the JACQUES Initiative, a program of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, in partnership with the Maryland AIDS Administration, sev
No Disparities by Race/Ethnicity in Risk of AIDS and Death Among HIV-Infected Patients in Kaiser Permanente's Integrated Delivery System, Research Study Finds: PRNewswire - July 20, 2009; -- Surprising Trend Toward Better Outcomes for Hispanics OAKLAND, Calif., July 20 /PRNewswire/ -- Kaiser Permanente researchers found no disparities by race or ethnicity in risk of AIDS and death among HIV-infected patients in a setting of similar access to care. This is despite lower Anti-Retroviral Therapy adherence
Genetic Variation Associated With Survival Advantage in African Americans With HIV: PRNewswire - July 20, 2009; WASHINGTON, July 20 /PRNewswire-USNewswire/ -- From the start of the HIV epidemic, it appeared that some of the people who were infected with the virus were able to ward off the fatal effects of the disease longer than others. Recent studies have begun to unravel the cause of this phenomenon, and new research suggests
New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies: PRNewswire - July 20, 2009; GRACE compares efficacy and safety of PREZISTA/ ritonavir in treatment-experienced women vs. men at 48 weeks BRIDGEWATER, N.J., July 20 /PRNewswire/ -- Data from a historic HIV study demonstrate that it is possible to recruit large numbers of women, African Americans and Latinos into U.S.-based HIV-1 treatment studies.
96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy: PRNewswire - July 20, 2009; BRIDGEWATER, N.J., July 20 /PRNewswire/ -- Ninety-six week pooled results from two Phase 3 studies (DUET-1 and DUET-2) showed that significantly more treatment-experienced HIV-1-infected adults with non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI) resistance had an undetectable viral l
New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed: PRNewswire - July 20, 2009; CAPE TOWN, South Africa , July 20 /PRNewswire/ -- New data became available today at the 5th International AIDS Society Conference from ARTEN ( Atazanavir / Ritonavir on a background of Tenofovir an
Shifting Scientific, Health Priorities and Global Economic Downturn Impact Investment in HIV Prevention R&D: PRNewswire - July 20, 2009; -- New report finds first decline in HIV vaccine R&D investment in a decade CAPE TOWN, South Africa , July 20 /PRNewswire-USNewswire/ -- A new report on investment in HIV prevention research in 2008 finds that HIV vaccine research funding levels decreased for the first time since investment trends have been tracked
BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan Africa: PRNewswire - July 19, 2009; TRAINING PROGRAMS IN UGANDA, SOUTH AFRICA AND MOZAMBIQUE IMPROVE LABORATORY PRACTICES, SAFETY AND PATIENT CARE CAPE TOWN, South Africa , July 19 /PRNewswire-FirstCall/ -- A collaboration between the U.S. President s Emergency Plan for AIDS Relief (PEPFAR) and BD (Becton, Dickinson and Company) has made significant prog
Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences: Product Could Represent a New, Once-Daily Antiretroviral Treatment Option: PRNewswire - July 16, 2009; CORK, Ireland , July 16 /PRNewswire/ -- Tibotec Pharmaceuticals today announced that it has entered into a license and collaboration agreement with Gilead Sciences , Inc. for the development and commercialization of a new once-daily fixed-dose antiretroviral product containing Tibotec s investiga
Justice Department Releases New Fact Sheet on the Rights of Persons With HIV or AIDS to Obtain Occupational Training and State Licensing: PRNewswire - July 16, 2009; WASHINGTON, July 16 /PRNewswire-USNewswire/ -- The Justice Department today released a new technical assistance fact sheet on legal requirements relating to admitting individuals with HIV or AIDS to occupational training schools and granting state licensure in occupations such as barbering, massage therapy and home hea
Improvements in Sexual and Reproductive Health of Teens and Young Adults Slowing: PRNewswire - July 16, 2009; After a period of improvement, trends in the sexual and reproductive health of U.S. teens and young adults have flattened, or in some instances may be worsening, according to a new report from the Centers for Disease Control and Prevention. CDC analyzed data from 2002-2007 from the National Vital Statistics System and
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV: PRNewswire - July 15, 2009; -- CCR5 Antagonist Evaluated in Novel Nucleoside-Sparing Regimen Designed to Provide Additional Treatment Options, Preserve other HIV Drugs for Subsequent Use KENILWORTH, N.J., July 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today announced that it has extended to stage two an ongoing Phase II
Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy: PRNewswire - July 13, 2009; DES PLAINES, Ill., July 13 /PRNewswire-FirstCall/ -- Abbott announced today that it has entered into an agreement with GlaxoSmithKline (GSK) to develop an automated molecular diagnostic test, based on polymerase chain reaction (PCR) technology, intended to screen non-small cell lung cancer (NSCLC) tumors for expression
Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission: First Program in Uganda to Provide Circumcision Services: PRNewswire - July 10, 2009; KAYUNGA, Uganda , July 10 /PRNewswire-USNewswire/ -- Uganda was the first country in sub-Saharan Africa to register a drop in adult national prevalence in HIV. The epidemic, however, remains serious as approximately one million Ugandans are HIV positive. Experts in the field have begun promoting a low cost and powerful
Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year: PRNewswire - July 8, 2009; -- With U.S. Leadership, Tide Turning in Fight against Three Diseases WASHINGTON, July 8 /PRNewswire-USNewswire/ -- Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.3 million people on
Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education: PRNewswire - July 8, 2009; The President s visit to Ghana is a perfect opportunity for him to reflect on the impact of his broken campaign promises on global AIDS and education, especially in Africa, and to honor those promises made to the American people, and to the world. - Paul Zeitz WASHINGTON, July 08 /PRNewswire-USNewswire/ -- On the eve
Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development: PRNewswire - July 7, 2009; -- IND or foreign regulatory equivalent submission anticipated in first half 2010 PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announced today the nomination of PSI-352938 ( PSI-938 ) as a lead development candidate from two series of purine analogs for the treatment of chronic hepat
Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies: PRNewswire - July 7, 2009; -- FHC Ranks 8th on Magazine s List of the top 100 Fastest-Growing Small Businesses Company Is Rated First among Healthcare Companies, and First among Six Illinois Businesses CHICAGO, July 7 /PRNewswire-FirstCall/ -- The Female Health Company (FHC) (Nasdaq-CM: FHCO) today announced that Fortune has ranked FHC eighth am
(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona: PRNewswire - July 2, 2009; NEW YORK, July 2 /PRNewswire/ -- Tuesday night saw the launch of (RED)ZONES at the first U2 360 Degrees concert in Barcelona where U2 kicked off their new tour to a rapturous sold out crowd of 90,000 fans. (RED)ZONES are prime location areas directly adjacent to the stage which will be present throughout the U2 tour. T
Keep a Child Alive Raises Over $130,000 During BET Awards Show Through mGive- Mobile Donation Program: PRNewswire - July 1, 2009; DENVER, July 1 /PRNewswire/ -- Alicia Keys appearance on the 2009 BET Awards Show Sunday night (June 28) raised more than $130,000 from more than 26,000+ mobile donors who texted their donations. Keep a Child Alive is the non-profit organization co-founded by Keys to provide health care and housing to children with HIV
Miami Physician Sentenced to 97 Months in Prison for Role in $10 Million Medicare Fraud Scheme: PRNewswire - June 29, 2009; WASHINGTON, June 29 /PRNewswire-USNewswire/ -- Miami physician Roberto Rodriguez, 54, was sentenced today to 97 months in prison for his role in a Medicare fraud scheme involving HIV infusion services, announced Assistant Attorney General Lanny A. Breuer of the Criminal Division, Acting U.S. Attorney Jeffrey H. Sloman
New Media-Led Effort Responds to AIDS Crisis in Black America: GREATER THAN AIDS Promotes Unity, Power of Community: PRNewswire - June 25, 2009; -- Multi-Platform Campaign Incorporates PSAs, Integrated Content and Community Activities MENLO PARK, Calif., June 25 /PRNewswire-USNewswire/ -- Today, leading U.S. media companies announced a new coordinated national campaign to mobilize Black Americans in response to AIDS and promote specific calls-to-action to preve
Global Business Coalition Recognizes Shell Petroleum Development Company for Niger Delta AIDS Response Program: PRNewswire - June 24, 2009; WASHINGTON, June 24 /PRNewswire/ -- The Global Business Coalition (GBC) announced today that Shell Petroleum Development Company (SPDC) has been named the first winner of the annual award for Partnership in Collective Action. GBC recognized SPDC for work in helping to prevent the spread of AIDS in the N
MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas: PRNewswire - June 22, 2009; WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The National Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas (http://www.maphiv.org/) that highlights the impact of the HIV/AIDS epidemic in communities across the United States . The Atlas makes information on HIV/AIDS prevalence rates available in a
MapHIV.org Shows Massachusetts' Suffolk County Seriously Impacted by HIV and AIDS: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas: PRNewswire - June 22, 2009; WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The National Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas (http://www.maphiv.org/) that highlights the impact of the HIV/AIDS epidemic in communities across the United States . The Atlas makes information on HIV/AIDS prevalence rates available in a
National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas: MapHIV.org Shows Vast Majority of Nation's HIV Burden Clustered in Only 20% of Counties: PRNewswire - June 22, 2009; WASHINGTON, June 22 /PRNewswire/ -- The National Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas (http://www.maphiv.org/) that highlights the impact of the HIV/AIDS epidemic in communities across the United States . The Atlas makes information on HIV/AIDS prevalence rates available in a single loc
GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois: PRNewswire - June 18, 2009; ATLANTA, June 18 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced today that it signed a proposal to discuss a cooperative a
House Subcommittee Markup Leaves Global Fund to Fight AIDS, TB, and Malaria in Crisis: PRNewswire - June 17, 2009; WASHINGTON, June 17 /PRNewswire-USNewswire/ -- The Global Fund to Fight AIDS, Tuberculosis, and Malaria is currently facing a major financing shortfall. While the Foreign Operations subcommittee provided a welcome increase over the President s request, today s markup suggests that the U.S. is going to fall far short of
National Minority Quality Forum to Release Groundbreaking National HIV/AIDS Atlas: PRNewswire - June 17, 2009; WASHINGTON, June 17 /PRNewswire-USNewswire/ -- On Monday, June 22, the National Minority Quality Forum will launch the groundbreaking HIV/AIDS Atlas of the United States at the Kaiser Family Foundation in Washington, DC. The Forum is releasing this Web-based Atlas ( http://www.maphiv.org) to highlight the local impact
Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development: PRNewswire - June 17, 2009; -- Collaboration will focus on the development of TMC207 and the discovery of new drugs to treat tuberculosis SEATTLE, June 17 /PRNewswire/ -- A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a
Protest: AHF to Renew Call for California 'Condoms in Porn' Law at Larry Flynt's Hustler/Hollywood Store: Monday, June 15th 9:00pm: PRNewswire - June 12, 2009; LOS ANGELES, June 12 /PRNewswire-USNewswire/ -- After the Los Angeles Times reported that as many as 16 actors and actresses in the adult entertainment industry recently tested positive for HIV, AIDS Healthcare Foundation (AHF) will host a press conference, protest and rally Monday, June 15th at 9:00pm at porn impresar
New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance: PRNewswire - June 12, 2009; -- Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the world s leading provider of diagnostic testing, information and services, today announ
WVU Doctor Works to Reduce Cancer Burden in Africa: PRNewswire - June 12, 2009; MORGANTOWN, W.Va., June 12 /PRNewswire-USNewswire/ -- In 2010, cancer will be the single leading cause of death worldwide, overtaking chronic illnesses such as heart disease and stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis and malaria combined. Almost three-quarters of new cases will occur in d
Unprecedented Scale-Up of Voluntary Male Circumcision Begins in Swaziland and Zambia: The Male Circumcision Partnership expands access to proven HIV prevention intervention: PRNewswire - June 11, 2009; WASHINGTON, June 11 /PRNewswire-USNewswire/ -- In a significant move from research on male circumcision to full-scale implementation, the Male Circumcision Partnership is launching a massive scale-up of voluntary male circumcision services in Swaziland and Zambia . The Partnership is supported by a five-y
Celebrities Come Together to Fight Pediatric AIDS: Star-studded Event with Concert by Miley Cyrus at the 20th Annual A Time For Heroes Family Picnic Sponsored by Disney to Benefit the Elizabeth Glaser Pediatric AIDS Foundation: PRNewswire - June 9, 2009; LOS ANGELES, June 9 /PRNewswire/ -- Celebrities helped create a generation free of HIV at the 20th annual A Time For Heroes Family Picnic, held June 7 in Los Angeles in support of the Elizabeth Glaser Pediatric AIDS Foundation. More than 80 of Hollywood s best-known names volunteered their time as heroes working carniv
Thomas R. Frieden, M.D., M.P.H., Begins Role as CDC Director and ATSDR Administrator: PRNewswire - June 8, 2009; ATLANTA, June 8 /PRNewswire-USNewswire/ -- Thomas R. Frieden, M.D., M.P.H., today became the 16th director of the Centers for Disease Control and Prevention (CDC) and administrator for the Agency for Toxic Substances and Disease Registry (ATSDR). He was named director of CDC by the White House and the Department of Hea
PHOENIX-AHF/Magic Johnson HIV Testing Caravan & Southwest Center for HIV/AIDS to Host Free HIV Testing Event at 'Off Chute Too': PRNewswire - June 8, 2009; -- Tuesday June 9th 4:00 PM to 7:00 PM -- LA to DC: Three Week, 14 City Free Mobile HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th-National HIV Testing Day LOS ANGELES, June 8 /PRNewswire-USNewswire/ -- Cumulative AIDS Cases in ARIZONA 1.1% of US total (10,975 AIDS
Rx for Africa, Inc. Signs Letter of Intent for Strategic Alliance with Rusan Pharma, Ltd. of India: PRNewswire - June 8, 2009; NEW YORK, June 8 /PRNewswire-FirstCall/ -- Rx for Africa, Inc. announced today the signing of a letter of intent for a strategic alliance with Rusan Pharma, Ltd., of Mumbai, India . The alliance commences immediately, with Rusan providing Rx for Africa Inc. the tuberculosis (TB) drug, RUCOX-4 (four drug combination)
More Than 80 Celebrities to Come Together at the 20th Anniversary A Time for Heroes Celebrity Carnival Sponsored by Disney to Benefit the Elizabeth Glaser Pediatric AIDS Foundation: PRNewswire - June 7, 2009; -- Star-studded Event with Concert by Miley Cyrus Takes Place on Sunday, June 7, in Los Angeles LOS ANGELES, June 7 /PRNewswire-USNewswire/ -- On Sunday, June 7, L.A. s most talked about family carnival and picnic turns 20! More than 80 celebrities will be on hand at the 20th annual A Time for Heroes Celebrity Carnival
Leaders of L.A. Gay & Lesbian Center and San Francisco AIDS Foundation, with 2,150 Cyclists, Decry Proposed Cuts in HIV Funding at Conclusion of AIDS/LifeCycle 8: PRNewswire - June 6, 2009; -- Participants in 545-mile trek from San Francisco to Los Angeles Raise $10.5 million LOS ANGELES, June 6 /PRNewswire-USNewswire/ -- Cheered by fans, friends, family and local residents, about 2,150 bicyclists streamed into Los Angeles today for the conclusion of the eighth annual AIDS/LifeCycle, a seven-day, 545-mile
Blair Underwood to Kick off AHF's U.S. HIV Testing Caravan, Monday June 8th, 11:00 AM (PST): PRNewswire - June 5, 2009; LA to DC: Three Week, 14 City Free HIV Testing Caravan Visits Hard-hit Southern US Cities; Arrives Washington, DC, on Saturday June 27th -- National HIV Testing Day LOS ANGELES, June 5 /PRNewswire-USNewswire/ -- In an effort to boost AIDS awareness and HIV prevention and testing efforts in some of the hardest hit regio
L.A. Gay & Lesbian Center, S.F. AIDS Foundation and 2,150 Cyclists Decry Proposed Cuts in HIV Services at Closing Ceremony of AIDS/LifeCycle: PRNewswire - June 5, 2009; WHAT: At the closing ceremony of AIDS/LifeCycle, the leaders of the L.A. Gay & Lesbian Center and the San Francisco AIDS Foundation, joined by more than 2,150 bicyclists from 41 states and 14 nations, will decry the cuts in HIV/AIDS-related services in the governor s proposed budget for California. With helmets cov
Data On Investigational Drug TMC207 for Treatment of MDR-Tuberculosis, Published in New England Journal of Medicine: Clinical Activity Of TMC207 shows ATP-Synthase is a Viable Target for treatment of TB: PRNewswire - June 3, 2009; MECHELEN, Belgium , June 3 /PRNewswire/ -- Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today. TMC207 is being developed by Tibotec BVB
'AIDS is DC's Katrina' Ad Challenges Obama to Act on U.S. Epidemic: PRNewswire - June 2, 2009; -- Provocative Katrina Ad Placed on Bus Shelters throughout Washington and Companion TV Spot Highlight CDC s Failure at HIV Prevention; Prod President Obama to Act on AIDS -- HIV Prevalence Rate in Washington Recently Surged Past 3% -- Higher than Lagos, Nigeria WASHINGTON, June 2 /PRNewswire-USNewswire/ -- Using Washi
IBM and EU Partners Create a Better Way to Fight AIDS Virus: EuResist HIV Treatment Prediction Tool Wins Top Honors in Computerworld Honors Program: PRNewswire - June 2, 2009; WASHINGTON, June 2 /PRNewswire-FirstCall/ -- IBM (NYSE:IBM) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Program Laureate for 2009. Developed by IBM researchers in Haifa, Israel , the project s new technologies and mathematical model
MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested': PRNewswire - June 2, 2009; -- National Campaign with the Kaiser Family Foundation, Planned Parenthood and Partners Triggers Youth Conversation, Helps Drive STD Testing -- STD Testing Doubles at Many Planned Parenthood Clinics During April NEW YORK, June 2 /PRNewswire/ -- In recognition of National STD Awareness Month (April), MTV, leading pop-cu
AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS: 2,150 cyclists to start San Francisco-to-Los Angeles ride May 31: PRNewswire - May 31, 2009; SAN FRANCISCO and LOS ANGELES, May 31 /PRNewswire-USNewswire/ -- More than 2,150 bicyclists from 41 states and 14 nations will stream out of San Francisco on May 31 en route to Los Angeles as participants in the colorful and emotional AIDS/LifeCycle, the world s largest annual HIV/AIDS fundraiser. The 545-mile trek is
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting: PRNewswire - May 28, 2009; HORSHAM, Pa., May 28 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that data related to several compounds will be presented at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla., from May 29 to June 2, 2009. The studies were sponsored by Centocor Ortho Biotech
Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.: PRNewswire - May 28, 2009; RESEARCH TRIANGLE PARK, N.C., MAY 28 /PRNewswire-USNewswire/ -- Family Health International announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project led by David C. Sokal, M.D.,
ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine: PRNewswire - May 26, 2009; HALIFAX, NS, May 26 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based, clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech s GTU(R) MultiHIV DNA plasmid with IVT s Depo
Thousands Rally in Anaheim to Help People With HIV/AIDS: Event raises $480,000 to make vital health and human services available through local nonprofit organizations: PRNewswire - May 22, 2009; IRVINE, Calif., May 22 /PRNewswire-USNewswire/ -- More than 5,000 people converged on Angel Stadium of Anaheim Saturday, May 16 for Orange County s largest annual rally against HIV/AIDS. Donations from OC AIDS Walk 2009 reached $480,000. More than 8,000 men, women and children are living with HIV/AIDS in our community.
AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns: UNAIDS Executive Director Calls for Action to Improve Delivery of PMTCT: PRNewswire - May 21, 2009; GENEVA, May 21 /PRNewswire-USNewswire/ -- In a dramatic meeting today at the UNAIDS headquarters in Geneva, members of the International Treatment Preparedness Coalition (ITPC) and AIDS-Free World met with the leaders and approximately 100 staff members of UNAIDS and WHO to present ITPC s latest Missing the Target repo
NeurogesX Receives European Commission Approval for Qutenza(TM): Approved for peripheral neuropathic pain in non-diabetic adults: PRNewswire - May 21, 2009; SAN MATEO, Calif., May 21 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX) , a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that the European Commission has formally granted marketing authorization of Qutenza(TM) 179 mg cutaneous patch (form
Programs to Prevent HIV in Newborns Failing in the Developing World - Over 900 Avoidable HIV Infections Every Day: PRNewswire - May 21, 2009; -- New multi-country research study finds neither newborns nor their mothers are receiving appropriate treatment and care to end this needless tragedy NEW YORK and GENEVA, May 21 /PRNewswire-USNewswire/ -- Global and national programs to prevent vertical (mother-to-child) transmission are in disarray and governments ar
The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision: A Celebration of Gloria Steinem's 75th Birthday: PRNewswire - May 21, 2009; NEW YORK, May 21 /PRNewswire-USNewswire/ -- Tonight the Ms. Foundation for Women will be joined by prominent members of the entertainment, business, philanthropic and not-for-profit communities in celebration of its co-founder Gloria Steinem s 75th birthday and the Ms. Foundation s 21st Annual Gloria Awards, a tribute
Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine: PRNewswire - May 20, 2009; ATLANTA, May 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that Chuck Panozzo, founder of the intern
Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013: PRNewswire - May 19, 2009; By 2018, Gilead s Quad Will Become the Highest-Selling Antiretroviral in the World s Major Markets, According to a New Report from Decision Resources WALTHAM, Mass., May 19 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues, finds that sal
Global Health Advocates Call for Pan-African Voices to Speak Up: Letter from an African Man Living with HIV/AIDS Presented to the White House: PRNewswire - May 19, 2009; -- It is not morally right for the President to cut down on the U.S. global health contribution, especially on AIDS. Cutting the budget for global AIDS funding is tantamount to genocide, and Mr. Obama shall be held accountable for deaths that will ensue. -- Felix Mwanza, Open Letter to President Obama, May 18, 2009
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope: PRNewswire - May 18, 2009; WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone. There are over 1.1 million people living with the vi
Piecing Together the HIV Prevention Puzzle: AVAC Report Assesses Progress in AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent Coordination and Leadership in Advance of Upcoming Results: PRNewswire - May 18, 2009; NEW YORK, May 18 /PRNewswire-USNewswire/ -- It s an exciting time in HIV prevention research. We will see results from a number of critically important HIV prevention research trials this year, as well as see the start of new trials around the world that will yield important answers in the years to come, said Mitchell
Novel Vaccine Approach Offers Hope in Fight Against HIV: PRNewswire - May 17, 2009; --Gene Transfer Technology May Lead to an HIV Vaccine PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using gene transf
Haiti Hosts Opening Ceremony of the 2009 International AIDS Candlelight Memorial: Worldwide Events Commence With the Announcement of a National HIV Testing Campaign in Haiti: PRNewswire - May 16, 2009; PORT-AU-PRINCE, Haiti , May 16 /PRNewswire-USNewswire/ -- The opening ceremony of the International AIDS Candlelight Memorial was held tonight in Haiti, kicking off over 1,000 Candlelight events in more than 100 countries as part of the world s oldest and largest HIV/AIDS grassroots mobilization event. Haiti was select
Media Call: Report Denounces Failure to Prevent Mother-to-Child Transmission of HIV in Developing World: Governments, UN agencies and donors at fault; researchers discuss findings, recommendations to change course: PRNewswire - May 15, 2009; WHEN: Thursday, May 21, 2009 - 9:30 a.m. EDT / 1:30 p.m. GMT TO REGISTER FOR THE CALL: Please provide your name, media/program affiliation and phone number to caitlin.hool@gabbe.com or jeff.lewis@gabbe.com or call (212) 220-4444 by Wednesday, May 20th, 2009 at 5:00 p.m. EDT. WHAT: Failing Women, Failing Children: HIV,
Many Americans Worry About How People With HIV/AIDS Fare in the U.S. Health System: PRNewswire - May 13, 2009; -- Research shows that support for increased funding coexists with fears and stigma NEW YORK, May 13 /PRNewswire-USNewswire/ -- Many Americans voice concern about how those infected with HIV fare in the U.S. health care system, according to Impressions of HIV/AIDS in America a new focus group study released today by Pu
Southern AIDS Living Quilt Posts 100th Video Patch During National Women's Health Week: PRNewswire - May 13, 2009; -- Video features HHS Deputy Director of the Office on Women s Health WASHINGTON, May 13 /PRNewswire-USNewswire/ -- The Southern AIDS Living Quilt (www.livingquilt.org), a unique web project that collects and shares video stories of women on the front lines of the fight against HIV/AIDS, today announced that it has pos
Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa: PRNewswire - May 13, 2009; HORSHAM, Pa., May 13 /PRNewswire/ -- Data from a study of managed-care cancer patients receiving chemotherapy and newly treated with erythropoiesis-stimulating agents (ESAs) found that the cumulative ESA cost with Epoetin alfa (EPO) was 29 percent lower than treatment with darbepoetin alfa (DARB). The analysis, publish
Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS: PRNewswire - May 13, 2009; WASHINGTON, May 13 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi received an Award of Courage from amfAR at the research foundation s conference today on future directions in the fight against HIV/AIDS. amfAR s Awards of Courage are bestowed each year on select individuals in recognition of the vision, determination,
GAA Calls For a Worldwide Response to President Obama's Global Health Budget Shortfalls: PRNewswire - May 13, 2009; The President and U.S. Congress need to hear world voices, especially voices from Africa, about the devastating impact of the President s broken campaign promises. - Dr. Paul Zeitz, GAA executive director WASHINGTON, May 12 /PRNewswire-USNewswire/ -- In an email sent today to more than 12,000 health advocates and orga
Victory! Colombian Government Cuts Price of Abbott's Lifesaving AIDS Drug Kaletra 55%, Says AHF: PRNewswire - May 11, 2009; -- Advocates Claim Victory as Government Cuts & Freezes Price at $1,067 USD for Public Institutions and $1,591 USD for Hospitals, Clinics & Private Sector-55% Less than Abbott s Previous Colombian Price -- Since January, Colombian, Mexican & US AIDS Advocates Protested Steep Price of Drug in Developing Coun
A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier: PRNewswire - May 8, 2009; HIV/AIDS Remains the Number One Global Health Threat WASHINGTON, May 8 /PRNewswire-USNewswire/ -- Today, HIV co-discoverers Drs. Robert C. Gallo, director of the Institute of Human Virology at the University of Maryland School of Medicine, and Luc A. Montagnier, president of the World Foundation for AIDS Research and
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials: PRNewswire - May 7, 2009; ABBOTT PARK, Ill., May 7 /PRNewswire-FirstCall/ -- The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH). This recommendation was made by the Cross-Network Laboratory Fo
AIDS Action Welcomes President's Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding: PRNewswire - May 7, 2009; WASHINGTON, May 7 /PRNewswire-USNewswire/ -- In his Fiscal Year 2010 (FY 10) budget request, President Barack Obama increased funding for HIV prevention and treatment and care by $107 million. In doing so, President Obama has put funding behind the vision set forth in his FY 10 budget outline of increasing resources to
Budget: Obama Retreats on Global AIDS, Says AHF: PRNewswire - May 7, 2009; -- As a Senator Last Year, Obama Voted for $9.6 Billion Annually in Funding for George Bush s Lifesaving Global AIDS Program; Now, President Proposes Only $6.6 Billion in FY 10 Budget for PEPFAR -- Obama Budget Calls for $51B for PEPFAR Over Six Years; Congress Voted for $48B Over Five Years WASHINGTON, May 7 /PRNewswi
Failed Abstinence-Only Programs Eliminated in 2010 Budget: Obama Brings Science and Evidence Back to Public Health Policy: PRNewswire - May 7, 2009; WASHINGTON, May 7 /PRNewswire-USNewswire/ -- The following is a statement of James Wagoner, President of Advocates for Youth: The Obama administration deserves praise for bringing science and evidence back to public health policy and jettisoning the ideological earmark known as abstinence-only. Now the ball is clearly
Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession: PRNewswire - May 7, 2009; DECLINING VISIBILITY, SENSE OF URGENCY ABOUT HIV/AIDS EPIDEMIC ABROAD MENLO PARK, Calif., May 7 /PRNewswire-USNewswire/ -- Two-thirds of the public supports maintaining (39%) or increasing (26%) U.S. government funding to improve health in developing countries, while fewer than a quarter (23%) say the government is spe
President Obama's FY10 Budget Breaks His Campaign Promises On Global Issues: PRNewswire - May 7, 2009; -- President Obama is betraying the trust of millions of people around the world, many of whom will die as a result of that betrayal. WASHINGTON, May 7 /PRNewswire-USNewswire/ -- President Obama s $3.55 trillion budget released today breaks four of his campaign promises and creates a total shortfall of $4.6 billion in
GAA Applauds Global Fund's Decision to Accelerate Support for Treatment Strategies to Prevent Mother-to-Child Transmission of HIV: PRNewswire - May 6, 2009; -- The Global Fund now has within its reach the potential to end pediatric AIDS. WASHINGTON, May 6 /PRNewswire-USNewswire/ -- At its spring meeting in Geneva, the Board of Directors of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), today agreed to enhance the Fund s response to HIV/AIDS by accel
Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama's Global Health Funding for FY10 as Released by the White House Tuesday, May 5, 2009: PRNewswire - May 5, 2009; WASHINGTON, May 5 /PRNewswire-USNewswire/ -- The following is a statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama s global health funding for FY10 as released by the White House, Tuesday, May 5, 2009: We are disappointed by the preliminary global health budget for
Aethlon Medical Discloses New HIV/AIDS Treatment Data: PRNewswire - May 5, 2009; SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) today disclosed new data resulting from its recent first-in-human application of the Aethlon Hemopurifier(R) to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). Aethlo
IBM and Medical Researchers Launch Effort To Find Flu Drug Treatments: Lab tests may begin in just weeks as a result of World Community Grid: PRNewswire - May 5, 2009; GALVESTON, Texas, May 5 /PRNewswire-FirstCall/ -- IBM (NYSE:IBM) and the University of Texas Medical Branch (UTMB) launched an effort using IBM s World Community Grid virtual supercomputer to allow laboratory tests on drug candidates for drug-resistant influenza strains and new strains, such as H1N1, in less than a mon
Gallo and Montagnier: A Global Call to Action From HIV Co-Discoverers This Friday: PRNewswire - May 4, 2009; WHO: HIV Co-Discoverers Robert C. Gallo and Luc A. Montagnier WHAT: A Global Call to Action From HIV Co-Discoverers HIV Remains a Global Threat WHEN: Friday, May 8, 2009 10 a.m. - 11 a.m. Time for one-on-one broadcast interviews immediately following the press conference - contact Nora Grannell at ngrannell@ihv.umaryla
Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research: PRNewswire - May 4, 2009; RICHMOND, Calif., May 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO), the world leader in the research and development of zinc finger DNA-binding proteins (ZFPs), announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The
Exclusive Song by Yusuf (Artist Better Known as Cat Stevens) Featured by (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa: PRNewswire - May 4, 2009; -- RELEASES EVERYTIME I DREAM FROM FORTHCOMING ALBUM roadsinger (To Warm You Through The Night) -- ISSUE ALSO FEATURES DISCOVERY SONG BY MELODY GARDOT LOS ANGELES, May 4 /PRNewswire/ -- This week s issue of (RED)WIRE, a new digital music magazine from (RED), premieres as the lead track a song from Yusuf (the artist bet
Clinical Update - Debio 025 in Hepatitis C: Debiopharm Starts Phase IIb Study After Record Time Patient Randomisation: PRNewswire - April 30, 2009; LAUSANNE, Switzerland , April 30/PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions, particularly in the field of oncology, announced that on April 7, 2009 the last patient was randomised to take part in a phase IIb clinical study w
'Routine HIV Screening Coverage Act' (Waters, D, CA) a 'Crucial Linchpin to Health Care Reform,' says AHF: PRNewswire - April 29, 2009; -- Bill Would Require Health Insurance Plans to Cover Routine HIV Tests Under the Same Terms as Other Routine Health Screenings. Legislation Could Spur Nationwide Compliance with CDC s 2006 HIV Testing Guidelines Recommending HIV Testing of All those 13-64 in Routine Health Settings WASHINGTON, April 29 /PRNewswire-USN
ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs: PRNewswire - April 29, 2009; FREDERICK, Md., April 29 /PRNewswire/ -- ImQuest BioSciences and Arisyn Therapeutics jointly announced today that they have entered into a strategic drug development partnership to provide support necessary to develop Arisyn s portfolio of novel inhibitors for the treatment of infectious disease and cancer. Arisyn has
AIDS Action Applauds Selection of Dr. Eric Goosby as Global AIDS Coordinator: PRNewswire - April 28, 2009; WASHINGTON, April 28 /PRNewswire-USNewswire/ -- AIDS Action Council commends President Obama and Secretary of State Clinton on today s nomination of Dr. Eric Goosby as Director of the Office of the Global AIDS Coordinator (OGAC). AIDS Action is pleased that the Office of the Global AIDS Coordinator will be led by such
Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening: PRNewswire - April 28, 2009; ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- Sigma-Aldrich (NASDAQ:SIAL) today announced the global release of MISSION(R) esiRNA, a pool of gene-specific siRNA that provides a novel and powerful approach to RNAi screening in mammalian cells. Unlike traditional synthetic RNAi, esiRNA (http://www.sigma.com/esirna) incor
IAPAC Lauds Obama Choice for Global AIDS Coordinator: PRNewswire - April 28, 2009; -- Goosby is a public servant who can get the job done CHICAGO, April 28 /PRNewswire-USNewswire/ -- The following statement was issued by Jose M. Zuniga, President/CEO of the International Association of Physicians in AIDS Care (IAPAC): The International Association of Physicians in AIDS Care (IAPAC) enthusiastically s
Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Public's Sense of Urgency Is Down, Even Among Some Higher Risk Groups: PRNewswire - April 28, 2009; -- Sense of Personal Risk Falls for Young Adults, Testing Rates Are Stagnant -- Amidst Call for Stepped Up Focus on Domestic HIV/AIDS, There Is Public Support for More Spending and the Public Believes Greater Efforts on Prevention Will Make a Difference WASHINGTON, April 28 /PRNewswire-USNewswire/ -- Less than a year a
Interim Results of Abbott's PROGRESS Study Show Rapid Viral Decline in Dual-Therapy Regimen of Kaletra(R) (lopinavir/ritonavir) and Raltegravir: PRNewswire - April 28, 2009; LIVERPOOL, England, April 28/PRNewswire/ -- Interim results of Abbott s PROGRESS study showed that Kaletra (R) combined with raltegravir suggested a more rapid initial viral load decline when compared to a traditional triple-drug combination therapy of Kaletra and
Kaiser Family Foundation Launches Daily Global Health Policy Report and Policy Tracking Tool As Part of New Web Gateway Focusing on U.S. Global Health Policy: PRNewswire - April 27, 2009; -- New Report Details the Structure and Funding Of U.S. Global Health Programs MENLO PARK, Calif., April 27 /PRNewswire-USNewswire/ -- With attention to global health rising on the U.S. policy agenda in recent years, the Kaiser Family Foundation today launched a set of new resources providing U.S. policymakers, non-gov
Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure: PRNewswire - April 27, 2009; LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury -- without reducing pleasure or
46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day': PRNewswire - April 27, 2009; -- President Clinton Supports Global Tribute to Inspire People to Mirror Mandela s Values LONDON, April 27/PRNewswire/ -- 46664 and the Nelson Mandela Foundation are calling on people around the world to support the creation of an official Mandela Day, to be held annually on July 18, Mr Mandela s birthday. This celebra
Global AIDS Alliance Fund Welcomes Eric Goosby to Office of The Global Aids Coordinator: PRNewswire - April 25, 2009; And urges him to take immediate action to keep the Obama Administration from breaking its promises to increase global AIDS treatment and prevention funding WASHINGTON, April 25 /PRNewswire-USNewswire/ -- Dr. Eric Goosby, who will be named Global AIDS Coordinator on Monday, has a unique opportunity to hold the Obama Adm
Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen: PRNewswire - April 25, 2009; -- Combination of R7227, protease inhibitor, and R7128, nucleoside polymerase inhibitor, shows significant potency in reducing viral load in patients with hepatitis C NUTLEY, N.J., BRISBANE, Calif., and PRINCETON, N.J., April 25 /PRNewswire-FirstCall/ -- Roche, InterMune, Inc. (NASDAQ:ITMN) and Pharmasset (NASDAQ:VRUS)
Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C: PRNewswire - April 24, 2009; -- Start of trial triggers $10 million milestone payment to Pharmasset PRINCETON, N.J., April 24 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) and Roche (Roche SWX: RO, ROG; Pink Sheets: RHHBY) today announced that the first patient has been dosed in a Phase IIb study of R7128, the nucleoside polymerase inhi
The 2009 Survey of Americans on HIV/AIDS: Implications for the Domestic HIV/AIDS Crisis: DC Briefing to Release Poll About Americans' Attitudes, Knowledge, and Experiences: PRNewswire - April 23, 2009; WASHINGTON, April 23 /PRNewswire-USNewswire/ -- On Tuesday, April 28, the Kaiser Family Foundation is hosting a briefing to release the 2009 Survey of Americans on HIV/AIDS. The new survey of the American public is the seventh major survey conducted by the Foundation on the issue since 1995. As Foundation President Dre
Comic Relief Invests GBP6.3m to Tackle Malaria: PRNewswire - April 23, 2009; LONDON, April 23/PRNewswire/ -- Just days ahead of World Malaria Day 2009 Comic Relief has awarded GBP6.3m in funding to Malaria Consortium and the Global Fund to help protect over 1m people in Africa from malaria. Comic Relief selected Malaria Consortium and the Global Fund to Fight AIDS, Tuberculosis and Malaria as r
The Female Health Company / HLL Lifecare Limited Receive National AIDS Control Organization of India Order for 1.5 Million FC2 Female Condoms: PRNewswire - April 23, 2009; CHICAGO, April 23 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Alternext: FHC) which manufactures and markets the FC1 and FC2 Female Condoms(R), today announces that its technical collaboration with HLL Lifecare Limited (HLL) (formerly Hindustan Latex Limited) has been successful in winning another order f
CBTU HIV/AIDS Community Conference: PRNewswire - April 23, 2009; PHILADELPHIA, April 23 /PRNewswire-USNewswire/ -- Please mark your calendars now and make plans to attend the Ending the HIV/AIDS Epidemic in Our Community Conference on Saturday, May 2, 2009 at the Prince of Peace Baptist Church, Rev. Robert V. Shipman, Pastor. The Church is located at 1801 North 31st Street, the corn
Vietnam Veterans of America Calls for Openness and Transparency in Addressing Contaminated Medical Equipment at VAMCs: PRNewswire - April 23, 2009; WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The health of patients who received endoscopic procedures at three VA Medical Centers may have been compromised by contaminated medical equipment. According to the Department of Veterans Affairs, the number of potentially affected patients now totals 10,797, including 6,3
Blood Transfusion and Outcomes: International panel of experts finds little evidence for transfusions improving health: PRNewswire - April 22, 2009; MILWAUKEE, Wis., April 22 /PRNewswire/ -- An exhaustive review and analysis of the medical literature by a panel of experts at the International Consensus Conference on Transfusion and Outcomes (ICCTO) held this month in Phoenix concluded that there is little evidence to support a beneficial effect from the greatest nu
Nobel Laureate Celebrates With Thomson Reuters, Drs. Clotet and Gatell Ten Years of HIV Updates: PRNewswire - April 21, 2009; BARCELONA, Spain , April 21 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters and Drs. Clotet and Gatell have invited Francoise Barre-Sinoussi, winner of the 2008 Nobel Prize in Medicine, to give a keynote speech to celebrate the 10th anniversary of Prous Science - Timely Topics in Medicine-SIDA. T
Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments: PRNewswire - April 20, 2009; PITTSBURGH, April 20 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has been selected by the Clinton HIV/AIDS Initiative (CHAI) under its UNITAID-funded projects as the primary supplier of fiv
Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure: PRNewswire - April 20, 2009; BASEL, Switzerland , April 20/PRNewswire/ -- New data published today in a major peer-reviewed journal, Annals of Internal Medicine, show that re-treatment with Pegasys(R) (peginterferon alfa-2a) plus Copegus(R) (ribavirin) provides previously-treated hepatitis C patients a second chance for a cure. The study results d
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients: PRNewswire - April 20, 2009; - Company will increase focus on HCV pipeline - Conference call at 8:00 AM ET today PRINCETON, N.J., April 20 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announced today that after a discussion with its independent Data Safety Monitoring Board (DSMB) and the FDA , the company has decided to voluntarily ter
Subaru of America CMO Tim Mahoney and Restaurateur Stephen Starr to receive ActionAIDS' Friend for Life Award April 30: PRNewswire - April 20, 2009; -- April 30th - Dining Out For Life ... A night of food and festivities for a great cause! PHILADELPHIA, April 20 /PRNewswire/ -- Every year since 1991, ActionAIDS has shown their appreciation for people who through their work, their vision, and their philanthropy have made a very real difference in the lives of men, w
SmartGene, Inc. Enters Collaboration with Virco Lab, Inc. to Enhance HIV Genotyping and Resistance Interpretation Services in US: PRNewswire - April 20, 2009; RALEIGH, N.C., April 20 /PRNewswire/ -- SmartGene, Inc., a provider of novel services for the management and analysis of genetic data, today announced a marketing and distribution collaboration with Virco Lab, Inc., to help US laboratories manage, analyze, and derive maximum benefit from their HIV sequences. Virco will
Jorge Villamizar, Yerbabuena, Hernan Romero, DJ D'marquesina to Play Their Part at Cielo Latino 2009 -- Cielo Latino, the annual fundraiser for the Latino Commission on AIDS, is the nation's largest fundraiser in the fight against HIV/AIDS in the Latino community: PRNewswire - April 20, 2009; NEW YORK, April 20 /PRNewswire/ -- Dennis deLeon, president of the Latino Commission on AIDS, announced today the musical line up that will play for Cielo Latino on May 12, 2009, at Cipriani Wall Street. The Latino Commission on AIDS is delighted to have Jorge Villamizar, formerly of Bacilos, and Yerbabuena as the head
Team Uncovers Discrepancy in Death Certificates Listing Suicide: PRNewswire - April 17, 2009; MORGANTOWN, W.Va., April 17 /PRNewswire-USNewswire/ -- Even though suicide outranks homicide as a cause of death in the United States , incomplete death certificates thwart healthcare policymakers who want to create prevention strategies - especially for black and Hispanic populations, a WVU study shows. The Insti
GSK and Pfizer Innovative Agreement Creates Specialist HIV Company: PRNewswire - April 16, 2009; LONDON, April 16/PRNewswire-FirstCall/ -- Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an innovative agreement to pool their HIV assets creating a new world-leading, specialist HIV company. The deal will see the drug giants combine their existing HIV product and their pipelines with GSK holding 8
Tobira Therapeutics Inc. Initiates Proof of Concept Study with TAK-652 for the Treatment of HIV: New phase 2a trial for CCR5 antagonist: PRNewswire - April 9, 2009; PRINCETON, N.J. and SAN DIEGO, April 9 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced that it has initiated a proof-of-concept study for TAK-652, a CCR5 antag
AIDS Organizations Support New HIV Testing Bill: PRNewswire - April 7, 2009; -- Praise bill as a move in the right direction NEW YORK, April 7 /PRNewswire-USNewswire/ -- Five AIDS service organizations today endorsed legislation proposed by State Senate Health Committee Chair Thomas Duane that would bring New York s HIV counseling and testing law up-to-date with the realities facing the epidemi
Gap's (PRODUCT)RED(TM) Artist Edition T-Shirts Combine Fashion & Art to Support the Global Fund to Fight AIDS, Tuberculosis and Malaria: PRNewswire - April 6, 2009; -- Gap Taps Nine New Artists to Design its Summer (PRODUCT)RED Artist Edition T-Shirt Collection to Help Eliminate AIDS in Africa SAN FRANCISCO, April 6 /PRNewswire/ -- With a classic Gap t-shirt as their canvas, today Gap revealed new designs from nine contemporary artists as part of its (PRODUCT)RED Artist Edition T-
VA Continues Notification Process for Veterans Affected by Reprocessing Issues: PRNewswire - April 3, 2009; WASHINGTON, April 3 /PRNewswire-USNewswire/ -- The Department of Veterans Affairs (VA) has announced 3,174 Veterans have already been notified of the results of testing they underwent recently; that testing was conducted because of improperly reprocessed endoscopy equipment that may have been used in their care. These
Making a Difference is as Easy as Dining Out! : Persons over 50 are fastest emerging carriers of HIV/AIDS in the U.S. Help Fight AIDS in Your City. Support Dining Out For Life, Thursday, April 30: PRNewswire - April 3, 2009; PHILADELPHIA, April 3 /PRNewswire/ -- Make a reservation to go out to eat on April 30, 2009 and know you are helping in the fight against HIV/AIDS. Dining Out For Life(SM) hosted by Subaru is a one-day fundraiser that generated over $3.9 million in donations for AIDS service providers across North America last year.
MTV Unwraps GYT: Get Yourself Tested: The All-American Rejects, Santigold, Good Charlotte, Big Boi, Asher Roth, Keri Hilson, Perez Hilton, and N.E.R.D. Evangelize Youth STD Testing: PRNewswire - April 2, 2009; -- National Campaign with the Kaiser Family Foundation, Planned Parenthood and Others includes On-Air Programming, Viral Online Media, SMS Testing Locator, and In-Clinic Outreach One in Two Sexually-Active Americans Contracts an STD by Age 25 NEW YORK, April 2 /PRNewswire-FirstCall/ -- MTV and the Kaiser Family Foundat
Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical: First and Only Once-weekly, Self-administered Alternative to Injections for Treatment of Vitamin B12 Deficiency: PRNewswire - April 1, 2009; WOODCLIFF LAKE, N.J., April 1 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE:PRX), today announced it has acquired the worldwide rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray from QOL Medical LLC.
Beating a Global Killer: HIV/AIDS: PRNewswire - April 1, 2009; GLENDALE, Calif., April 1 /PRNewswire-FirstCall/ -- Immunotech Laboratories, Inc. Immunotech Laboratories announces successful Participation in DART conference in Puerto Rico with its abstract Irreversible Pepsin Fraction (IPF) displays significant antiretroviral activity via specific novel cytokine stimulation in vitr
Leading HIV Experts Convene to Tackle the Challenge of Late Presentation in Europe: PRNewswire - March 31, 2009; -- A third of HIV-infected persons in UK do not present for screening and treatment until late in infection increasing morbidity and decreasing their quality of life.(1,2,3) LONDON, March 31/PRNewswire/ -- Almost three decades after the discovery of HIV/AIDS, and despite big medical advances, there are still a signific
ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C.: PRNewswire - March 31, 2009; FREDERICK, Md., March 31 /PRNewswire/ -- ImQuest Life Sciences today presented important new results on the continued development of the pyrimidinedione small molecules as antiviral agents at the 13th International Symposium on Viral Hepatitis and Liver Disease meeting held last week in Washington D.C. ImQuest s screen
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R): PRNewswire - March 30, 2009; PITTSBURGH, March 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food and Drug Administration ( FDA ) under the President s Emergency
Wilmer Valderrama to Co-Host Cielo Latino with Miss Universe Dayana Mendoza: Cielo Latino, the annual fundraiser for the Latino Commission onm AIDS, is the Nation's Largest Fundraiser in the fight against HIV/AIDS in the Latino community: PRNewswire - March 30, 2009; NEW YORK, March 30 /PRNewswire/ -- Dennis deLeon, president of the Latino Commission on AIDS, announced Wilmer Valderrama and Miss Universe Dayana Mendoza as co-hosts for Cielo Latino on May 12, 2009 at Cipriani Wall Street. The Latino Commission on AIDS is honored and joyful to have the talent and support of Miss Univ
South Africa: AHF to Launch New State-of-the-Art Free AIDS Treatment Clinic Location in Umlazi: PRNewswire - March 28, 2009; -- After Seven Years of Growth, Ithembalabantu People s Hope AIDS Clinic Moves to New, Larger Freestanding Site at Umlazi s Ithala Centre. Formal Dedication and Ribbon-cutting Ceremony Set for Tuesday, March 31st -- AHF to Provide Free Mass HIV Testing during Daylong Celebration and Launch with Goal of 500 Tests DU
ImQuest Presentations at Keystone Symposium Focus on Advancements in Their Therapeutic and Microbicide Development Programs: PRNewswire - March 25, 2009; FREDERICK, Md., March 25 /PRNewswire/ -- ImQuest Life Sciences presented their latest biological results supporting the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the Prevention of meeting being held in Keystone, Colorado. The presentations highlighted new data supporting the s
Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education: PRNewswire - March 24, 2009; MAITLAND, Fla., March 24 /PRNewswire/ -- Florida farmers have launched a new foundation to benefit farmworkers, announcing today an initial round of $160,000 in funding for three programs related to child care, health care and education for the farmworker community in South Florida. For its inaugural projects, the Farm
American Lung Association Salutes Fellow Advocates in the Fight Against Tuberculosis on 2009 World TB Day: PRNewswire - March 24, 2009; WASHINGTON, March 24 /PRNewswire-USNewswire/ -- Statement from Stephen J. Nolan, Chairman of the American Lung Association: One hundred and five years after Dr. Edward Livingston Trudeau founded our health organization and dedicated it to eradicating Tuberculosis (TB), the American Lung Association joins thousands of i
Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB): PRNewswire - March 24, 2009; SUNNYVALE, Calif. March 24 /PRNewswire-FirstCall/ -- Cepheid (NASDAQ: CPHD) today announced details of technology expected to revolutionize the speed of diagnosis of Mycobacterium tuberculosis (TB) and the resistance to common drug treatment for the disease. The new test technology, developed in partnership with Founda
Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients: PRNewswire - March 23, 2009; -- Danya Presents Findings of Pilot Study at East African Health Conference in Kenya SILVER SPRING, Md., March 23 /PRNewswire/ -- Danya International, Inc. (Danya), a communications, research, and technology firm, will share the results of a pilot study on the effectiveness of mobile video-enabled phones in meeting the
Pelosi Statement on Reintroduction of the Early Treatment for HIV Act: PRNewswire - March 20, 2009; WASHINGTON, March 20 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi, along with Reps. Eliot Engel (D-NY) and Ileana Ros-Lehtinen (R-FL), reintroduced the Early Treatment for HIV Act (ETHA) this week with a bipartisan group of 44 original co-sponsors. Speaker Pelosi released the following statement: Effective drug trea
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union: Broad Label Indicated for Peripheral Neuropathic Pain in Non-Diabetic Adults: PRNewswire - March 19, 2009; -- Conference Call Scheduled Friday, March 20 at 9am ET SAN MATEO, Calif., March 19 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that the European Medicines Agency s (EMEA) Committee for Me
The NewsHour With Jim Lehrer Reports From South Africa on Renewed Efforts to Combat HIV/AIDS and Tuberculosis: PRNewswire - March 19, 2009; -- Series marks the launch of the NewsHour s Global Health Unit, funded by the Gates Foundation WASHINGTON, March 19 /PRNewswire-USNewswire/ -- The NewsHour with Jim Lehrer s Global Health Unit launches its first series of reports next week -- March 23 - 27, 2009. NewsHour Senior Correspondent Ray Suarez reports from
Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting: PRNewswire - March 18, 2009; SILVERTHORNE, Colo., March 18 /PRNewswire-USNewswire/ -- Keystone Symposia on Molecular and Cellular Biology will mark the 25th anniversary of its first HIV/AIDS meeting in 1984 when it convenes its scientific conferences on Prevention of HIV/AIDS and HIV Immunobiology: From Infection to Immune Control at Keystone Reso
Pope Not Infallible on Condoms: PRNewswire - March 18, 2009; WASHINGTON, March 18 /PRNewswire-USNewswire/ -- The Vatican has yet again been forced to revise statements made by Pope Benedict XVI as he embarked on a foreign trip. En route to Cameroon on March 17, the pope claimed that condom use would aggravate the problem of HIV. A transcript of the pope s comments on the Vatican
Partnership to Prevent HIV Among Vulnerable Russian Youth: PRNewswire - March 18, 2009; -- USAID, HealthRight International and Johnson & Johnson formalize a partnership to prevent the spread of HIV among street children and at-risk youth in St. Petersburg, Russia . WASHINGTON, March 18 /PRNewswire-USNewswire/ -- A public-private partnership to prevent the spread of HIV and increase access to HIV trea
'REAL' Sex Education for America's Youth: Statement by James Wagoner, President, Advocates for Youth: PRNewswire - March 17, 2009; WASHINGTON, March 17 /PRNewswire-USNewswire/ -- The re-introduction of the Responsible Education About Life (REAL) Act represents both a beginning and an end. A beginning, because REAL will bring science and common sense back into public health policy. After eight long years of ideology trumping science under the Bush
The Pope is Wrong on Condoms: PRNewswire - March 17, 2009; WASHINGTON, March 17 /PRNewswire-USNewswire/ -- Jon O Brien, president of Catholics for Choice, issued a response to Pope Benedict s statement on condom use. As the pope traveled to Africa, he chose this moment to make what appears to be his first unequivocal statement opposing condom use. In an interview on the papal
Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings: PRNewswire - March 13, 2009; RESTON, Va., LONDON and GENEVA, March 13 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in education for healthcare professionals, and NAM, an award-winning community-based HIV information provider, have been named the official providers of online conference coverage and news from the 5th Internationa
GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results: PRNewswire - March 12, 2009; ATLANTA, March 12 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company focused on development of an HIV/AIDS vaccine, today announced its financial results for the fourth quarter and year ended December 31, 2008, and provided a summary of recent operational high
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor: PRNewswire - March 12, 2009; -- Provides first affordable protease inhibitor for patients in developing countries - Complements recent WHO approval earned for the same product PITTSBURGH, March 12 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5%
U.S. Resumption of UNFPA Funding to Boost Women's Health and Rights: PRNewswire - March 12, 2009; UNITED NATIONS, New York, March 12 /PRNewswire-USNewswire/ -- Yesterday s action by President Barack Obama to pave the way for the release of United States funding for UNFPA, the United Nations Population Fund, reminds the world of his commitment to women s health, rights and equality, according to UNFPA Executive Dire
U.S. Food and Drug Administration Approves New Female Condom: Center for Health and Gender Equity Applauds Expansion of HIV Prevention Options for Women and Men Worldwide: PRNewswire - March 11, 2009; WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Today, the U.S. Food and Drug Administration ( FDA ) granted regulatory approval to the FC2 female condom, a lower-cost, second generation product manufactured by the Female Health Company -- a move widely praised by HIV/AIDS and women s health and rights advocates global
USAID and IOM Announce HIV Prevention and Care for Farm Workers: PRNewswire - March 11, 2009; PRETORIA, South Africa , March 11 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) and International Organization for Migration (IOM) in Southern Africa launched a new program to reduce HIV vulnerability of farm workers in South Africa s Limpopo and Mpumalanga Provinces. The three-ye
Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund: PRNewswire - March 11, 2009; -- Bill Ensures Greater Prevention, Treatment and Care Services for People around the World Affected by AIDS, Tuberculosis and Malaria WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Late yesterday the U.S. Senate voted to pass H.R. 1105, the Omnibus Appropriations bill for fiscal year 2009. The bill, passed by the Hou
Female Health Company Receives FDA Approval for FC2 Female Condom(R): Lower Cost Female Condom Increases Access to Woman-Initiated Protection Against HIV/AIDS: PRNewswire - March 11, 2009; CHICAGO, March 11 /PRNewswire/ -- The Female Health Company (NYSE Alternext: FHC) today announced approval from the U.S. Food and Drug Administration ( FDA ) for the company s FC2 Female Condom(R) (FC2), a woman-initiated barrier method that helps to protect against sexually transmitted infections (STIs), HIV/AIDS, and
Specialists are Highly Satisfied with the Safety and Efficacy of Atripla and Isentress in the Treatment of HIV Patients: PRNewswire - March 11, 2009; -- A CCR5 Antagonist That is Dosed Once Daily Could Earn an 18 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe, According to a New Report from Decision Resources WALTHAM, Mass., March 11 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceuti
New Research Released at Annual Society for Adolescent Medicine Meeting Provides Vital Insights into Adolescent Health Issues: PRNewswire - March 10, 2009; BLUE SPRINGS, Mo., March 10 /PRNewswire/ -- New research being released at the annual meeting of the Society for Adolescent Medicine (SAM) reveals significant results about how adolescents navigate their world and where their priorities lie. The theme of the meeting is E-teens and how teens incorporate technology into
FHSSA Calls Attention to National Women and Girls HIV/AIDS Awareness Day: PRNewswire - March 9, 2009; -- Non-profit Announces Three Partnerships in Kenya and One in Uganda ALEXANDRIA, Va., March 9 /PRNewswire-USNewswire/ -- On March 10, women and girls throughout the United States and around the world, join together to encourage dialogue on the increasing impact of HIV/AIDS.
YWCAs to Observe National Women and Girls HIV and AIDS Awareness Day on March 10th: PRNewswire - March 9, 2009; -- New Public Service Ad Aimed at Young Women WASHINGTON, March 9 /PRNewswire/ -- YWCAs across the country are joining the U.S. Department of Health and Human Services Office on Women s Health in observing National Women and Girls HIV and AIDS Awareness Day on March 10 by hosting a variety of activities, such as educat
Global War on Drugs Takes Devastating Toll on Human Lives, Advocates Say: High Level Meeting Convenes in Vienna to Chart Future of Drug Control Efforts: PRNewswire - March 5, 2009; NEW YORK, March 5 /PRNewswire-USNewswire/ -- In advance of a United Nations meeting meant to set the direction of drug policy for the next decade, the Open Society Institute today released a new report documenting the costs to health and human rights of current, repressive approaches to drug control. Country delegates
HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science: PRNewswire - March 5, 2009; -- Tibotec joins other leaders from academia, industry and government in collaboration to fight HIV YARDLEY, Pa., March 5 /PRNewswire/ -- A group of leading HIV experts call for the exploration of a new approach to treating HIV - one that could ultimately help eradicate the virus - through a collaboration involving aca
World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT: Introduced by President Bill Clinton, BMP Films and MTV Bring Academy Award-Winner Dustin Lance Black's ("Milk") Story of The Real World's Pedro Zamora To Life: PRNewswire - March 4, 2009; -- MTV and World Class Partners to Help Mobilize Young People to Get Tested During STD Awareness Month SANTA MONICA, Calif., March 4 /PRNewswire/ -- MTV, mtvU, LOGO and MTV Tr3s, with subtitles in Spanish, will present the world television premiere of Pedro, a movie based on the remarkable life of The Real World s Pedr
PSI Brings Tennis Star Anna Kournikova to Haiti Bringing Hope and Assistance to Child Slaves: PRNewswire - March 4, 2009; WASHINGTON, March 4 /PRNewswire-USNewswire/ -- Anna Kournikova has just returned from her first visit to Haiti , where she witnessed firsthand the combined effects of years of poverty, violence and natural disasters on the health of the local population. It was completely and devastatingly humbling to experience it all
Illinois Advocates Take on Health Insurance Industry: Coalition of Health and Consumer Advocates Launch Statewide Campaign Aimed at Tackling Unfair Industry Practices & Soaring Costs: PRNewswire - March 4, 2009; SPRINGFIELD, Ill., March 4 /PRNewswire-USNewswire/ -- As the economy worsens, soaring health insurance rates and unfair industry practices are leaving a growing number of individuals and businesses struggling when it comes to health care. Today, advocate groups from across the state converged on the State Capitol, join
Gene Therapy: Généthon Produces the First Batch of HIV-Derived Vectors in Europe for use in a Human Clinical Trial: PRNewswire - March 3, 2009; EVRY, France , March 3/PRNewswire/ -- Genethon, the french laboratory created and funded by the AFM (French Association against Myopathies) using donations from Téléthon, has announced on the 20th of February that it has produced, controlled and released a batch of lentiviral vectors derived from the human immunodefici
Largest Study to Date Compares Cholesterol Treatment in HIV Patients & Patients Without HIV Infection: PRNewswire - March 2, 2009; OAKLAND, Calif., March 2 /PRNewswire/ -- A new study in the online issue of Annals of Internal Medicine has found that cholesterol medications can work well among certain HIV patients who are at risk for cardiovascular disease. Though HIV patients are at higher risk for cardiovascular disease in part due to lipid abnor
Dr. Jim Yong Kim Appointed 17th President of Dartmouth College: Dedicated Educator and Humanitarian Has Provided Visionary Leadership in Academia, Public Policy and Global Health: PRNewswire - March 2, 2009; -- Continues Long Tradition of Dartmouth Presidents Who Have Had Significant Impact On the World Stage and in the Classroom HANOVER, N.H., March 2 /PRNewswire-USNewswire/ -- Jim Yong Kim, M.D., Ph.D., Chair of the Department of Global Health and Social Medicine at Harvard Medical School, has been elected the 17th Presi
The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project: As HIV/AIDS epidemic expands in the U.S, NAPWA and POZ reinvigorate AIDS activism: PRNewswire - March 2, 2009; WASHINGTON, March 2 /PRNewswire-USNewswire/ -- The National Association of People with AIDS (NAPWA) and POZ magazine today announced the launch of a new initiative known as The Denver Principles Project. The project aims to encourage a community-wide recommitment to the historic Denver Principles -- a self-empowerment
AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy: PRNewswire - February 26, 2009; WASHINGTON, Feb. 26 /PRNewswire-USNewswire/ -- AIDS Action congratulates Jeffrey Crowley, an openly gay man with significant knowledge and experience in health care and HIV/AIDS for his appointment as Director of the Office of National AIDS Policy (ONAP). He joins a well-respected and dedicated team in the Executive Of
Cascade of Studies, New Clinical Tests Build the Case for Genetic Testing in Pharmacy Care Says Medco Expert: PRNewswire - February 26, 2009; FRANKLIN LAKES, N.J., Feb. 26 /PRNewswire-FirstCall/ -- With more powerful, expensive and potentially dangerous medicines reaching the market on a daily basis, the time has come to leverage genetic tests that provide physicians with the confidence that they have prescribed the precise drug and dose tailored to their pa
ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria: PRNewswire - February 25, 2009; HALIFAX, NS, Feb. 25 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed a collaborative agreement with the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), in Maryland, USA. The research collaboration involves formula
Mylan's Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor: Provides first affordable protease inhibitor for patients in developing countries: PRNewswire - February 25, 2009; PITTSBURGH, Feb. 25 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5% controlling interest, received the first and only World Health Organization (WHO) approval for Lopinavir/
International Partnership for Microbicides Receives US $130 Million from UK Government and the Gates Foundation: PRNewswire - February 24, 2009; -- New support will accelerate development of new tools to help women protect themselves from HIV SILVER SPRING, Md., Feb. 24 /PRNewswire-FirstCall/ -- The International Partnership for Microbicides (IPM) announced today that it has received a total of US $130 million in grants from the UK Department for International
UN Reception Highlights Multi-Sector Partnerships in Global Public Health: Public and private health stakeholders working together to improve health in the developing world: PRNewswire - February 23, 2009; NEW YORK, Feb. 23 /PRNewswire-USNewswire/ -- Promoting health among the world s poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today, highlighting the power of partnerships in
Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched: PRNewswire - February 23, 2009; RESEARCH TRIANGLE PARK, N.C., Feb. 23 /PRNewswire-USNewswire/ -- The Clearinghouse on Male Circumcision for HIV Prevention -- www.malecircumcison.org -- was launched today. The Web site is designed to generate and share authoritative information about the role of male circumcision in HIV prevention. The Clearinghouse w
17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million: Sir Elton John Performed With Special Guest Raphael Saadiq: PRNewswire - February 23, 2009; LOS ANGELES, Feb. 23 /PRNewswire/ -- Sir Elton John and David Furnish hosted the 17th Annual Elton John AIDS Foundation (EJAF) Academy Awards(R) viewing party. The event was held on Sunday, February 22, 2009 at the Pacific Design Center and was co-sponsored by Chopard, Jo and Raffy Manoukian and Vh1. EJAF s party to ce
Global AIDS Alliance Sounds Alarm on Potential Budget Cuts: AIDS Leaders Call on President Obama to Support Effective, Life-saving Programs: PRNewswire - February 23, 2009; WASHINGTON, Feb. 23 /PRNewswire-USNewswire/ -- Amid initial indications that the administration s first budget will flat-line funding for global health, the Global AIDS Alliance is calling on President Obama, Vice President Biden and Secretary of State Hillary Clinton to keep their campaign commitments to scale up the
GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA: PRNewswire - February 20, 2009; -- Trials in South America to Follow ATLANTA, Feb. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced the first in
ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs: PRNewswire - February 20, 2009; FREDERICK, Md., Feb. 20 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the 16th Conference on Retroviruses and Opportunistic Infections held last week in Montreal. Presentations focused on the results of I
'Project Runway' Designer in San Francisco to Educate About Living with HIV and Combat Stigma Associated with the Disease: PRNewswire - February 20, 2009; -- Jack Mackenroth to kick off 2009 Living Positive By Design local tour at largest Academy Awards(R) party outside Hollywood SAN FRANCISCO, Feb. 20 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is visiting San Francisco for the Academy of Friends annual Academy Awards Night Ga
Rev. Byamugisha of Uganda to Receive Niwano Peace Prize: PRNewswire - February 20, 2009; TOKYO, Feb. 20 /PRNewswire/ -- The Niwano Peace Foundation announced Friday it will award the 26th Niwano Peace Prize to Rev. Canon Gideon Baguma Byamugisha, an Anglican priest of Uganda , in recognition of his work to uphold the dignity and human rights of people living with HIV/AIDS. An award presentation ceremon
Top Latin American Television Companies Commit to Addressing AIDS: Broadcasters Join Global Response to Stem Spread of HIV and Challenge Stigma: PRNewswire - February 18, 2009; MENLO PARK, Calif., Feb. 18 /PRNewswire-USNewswire/ -- Senior executives of leading media companies from Latin America announced the establishment of the Iniciativa de Medios Latinoamericanos sobre el SIDA (IMLAS) -- the first Latin American Media Partnership on HIV/AIDS. This announcement follows a meeting last month
Jack Mackenroth, Reality Television Star From "Project Runway" To Educate About Living with HIV and Combating Stigma At Academy of Friends' Academy Awards Night Gala in San Francisco: PRNewswire - February 17, 2009; WHO: Jack Mackenroth, from the hit reality television series Project Runway, will be in San Francisco for the largest Academy Awards(R) party outside Hollywood, representing Living Positive By Design, his national HIV and AIDS education initiative. WHY: Through Living Positive By Design, Jack will highlight the importa
Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609: PRNewswire - February 17, 2009; ROCKVILLE, Md., Feb. 17 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, today announced the receipt of a Small Business Innovation Research (SBIR) Phase I Grant from the National Institute of Allergy and Infectious Diseases (NIAID), National Institut
Helping Young Women Succeed in Today's Unpredictable World: Because the unexpected happens, www.WhatWillYourPlanBe.com offers post college-aged women expert guidance in career, financial planning and sexual health: PRNewswire - February 17, 2009; MONTVALE, N.J., Feb. 17 /PRNewswire/ -- Many young women enter the real world expecting that life will go according to plan, particularly when it comes to their careers, finances and relationships. Unfortunately, the reality is that the unexpected often happens -- a looming problem especially in today s challenging eco
Tony Blair and Robert Gallo Among 2009 Dan David Prize Winners: Three $1 Million Awards to be Presented: PRNewswire - February 16, 2009; TEL AVIV, Israel , February 16/PRNewswire/ -- The international Dan David Prize, which annually awards three prizes of US$1 million each for outstanding achievement, announced the names of its 2009 laureates today. The Dan David Prize is named after international businessman and philanthropist Dan David and is headquar
i.HUG Foundation Receives International Grant: Hires a School Nurse to Improve Student Health and Learning: PRNewswire - February 13, 2009; KABALAGALA, Uganda , Feb. 13 /PRNewswire/ -- In the midst of the AIDS crisis and other rampant diseases that have ravaged its impoverished community, the Kabalagala Community Academy (KCA) has finally begun to take its first steps toward healing. A $5,000 grant from the Virginia Gildersleeve International Foundation ha
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy: PRNewswire - February 11, 2009; BRIDGEWATER, N.J., Feb. 11 /PRNewswire/ -- Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., today announced the availability of a lower-dose (75 mg) formulation of PREZISTA (darunavir) for pediatric patients with HIV. The announcement follows the FDA approval of PREZI
GeoVax Update Provided at the BIO CEO & Investor Conference 2009: PRNewswire - February 11, 2009; ATLANTA, Feb. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that Robert McNally, Ph.D., Chief Execut
Increasing Diversity of HIV Strains Impacts Diagnostic Test Accuracy: Reports at CROI Meeting Confirm Rising Prevalence of Non-B HIV Subtypes in the United States: PRNewswire - February 10, 2009; MONTREAL, Feb. 10 /PRNewswire-FirstCall/ -- As genetically divergent strains of the HIV virus become increasingly prevalent in the United States , the ability of clinicians to effectively monitor progress of anti-viral drug therapies depends on the capacity of viral load assays to accurately quantitate, or measure, the
Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study: Results of NIH-sponsored Clinical Trial to be Presented at Retrovirus Conference: PRNewswire - February 9, 2009; LEXINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced today that a National Institutes of Health (NIH)-sponsored clinical study found that participating women who received PRO 2000, the Company s candidate vaginal microbicide for HIV prevention, had an approximately 30
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide: PRNewswire - February 9, 2009; Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides, issued the following statement on the results of the Phase II/IIb safety and effectiveness study of BufferGel and PRO2000 (0.5 percent concentration): SILVER SPRING, Md., Feb. 9 /PRNewswire/ -- The Microbicide Trials Network, a worldwide collabo
ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections: PRNewswire - February 9, 2009; FREDERICK, Md., Feb. 9 /PRNewswire/ -- ImQuest Life Sciences today presented important new results on the continued development of their small molecule inhibitor of HIV-1 at the 16th CROI meeting held this week in Montreal. The presentation highlighted the advanced development of ImQuest s lead HIV pyrimidinedione inhi
Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer: PRNewswire - February 9, 2009; MONTREAL, Feb. 9 /PRNewswire/ -- Sequoia Pharmaceuticals presented positive results today from two phase 1 studies in healthy volunteers and preclinical studies on SPI-452, a novel pharmacokinetic enhancer (PKE) with no inherent antiviral activity. Pharmacokinetic enhancers increase drug levels of co-administered agent
Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening: PRNewswire - February 9, 2009; MONTREAL, Feb. 9 /PRNewswire-FirstCall/ -- A new HIV antigen-antibody combination assay, currently available in Europe, can be useful for high- volume screening to identify individuals with acute HIV infection, who would be missed by traditional HIV antibody tests, according to research presented by Johns Hopkins Unive
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV: PRNewswire - February 6, 2009; CAMBRIDGE, Mass. and LONDON, Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) and GlaxoSmithKline (GSK) today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899. IDX899 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) in Phase II
New Clinical Study Presented at the Society for Critical Care Medicine Shows Value of Pulse CO-Oximetry(TM) to Identify Acquired Methemoglobinemia: PRNewswire - February 6, 2009; 1 out of 7 HIV+ Patients Receiving Dapsone Therapy at Significant Health Risk Due to Dangerously High Levels of Methemoglobin IRVINE, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Masimo (NASDAQ:MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that a n
Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill: PRNewswire - February 6, 2009; KENSINGTON, Md., Feb. 6 /PRNewswire-USNewswire/ -- Psoriasis Cure Now, a nonprofit patient advocacy organization, has launched a micro-Web site, www.StimulateResearch.com, to help everyday Americans interested in medical research be heard in the stimulus debate that has been dominated by powerful lobbyists and special
Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine): PRNewswire - February 5, 2009; BRIDGEWATER, N.J., Feb. 5 /PRNewswire/ -- Tibotec, Inc. today announced it has submitted an application to the U.S. Food and Drug Administration ( FDA ) seeking traditional approval for INTELENCE(TM) (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). The application for traditional approval
American Heart Association Rapid Access Journal Report: HIV Patients With Diabetes, Heart Disease Have Higher Risk of Heart Events: PRNewswire - February 3, 2009; Study highlights: -- HIV patients with coronary heart disease or diabetes are at a higher risk for subsequent coronary heart disease events than HIV patients without heart disease or diabetes. -- Targeted interventions, such as regular physical exercise, smoking cessation and cholesterol-lowering drugs, are needed to r
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS: Therapeutic Approach Provides HIV-Resistant Immune Cells: PRNewswire - February 3, 2009; RICHMOND, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS. Based on Sangamo s zinc finger DNA-binding protein nuclease (ZFN) t
Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research: PRNewswire - February 2, 2009; BALTIMORE, Feb. 2 /PRNewswire-USNewswire/ -- The Robert C. Gallo Foundation for AIDS and Virus Research today announced the appointment of Franco Nuschese as director of international relations. The foundation supports Dr. Gallo and his colleagues, who are internationally known for expertise in HIV prevention, treatmen
University of Minnesota's Internationally Recognized Stem Cell Experts Available for Interviews on What Lifting the Federal Funding Restrictions Will Mean to Stem Cell Research and to Patients Who Stand to Benefit: PRNewswire - January 29, 2009; MINNEAPOLIS/ST. PAUL, Minn., Jan. 29 /PRNewswire-USNewswire/ -- U.S. President Barack Obama is expected to support removing federal funding restrictions on human embryonic stem cells (hESC) research and is looking to Congress to introduce legislation to act on the issue. On Aug. 9, 2001, the Bush administration cut off
Advocates Call on Legislature to Stop Proposed Rx Cuts to the Elderly and Poor: Governor's Budget Eliminates EPIC and Medicaid Wrap Coverage for Prescription Drugs: PRNewswire - January 28, 2009; ALBANY, N.Y., Jan. 28 /PRNewswire-USNewswire/ -- Members of the New York State Medicare Part D Coalition, including AARP, the Empire Justice Center, Medicare Rights Center, The Legal Aid Society, Selfhelp Community Services and Statewide Senior Action, called on the New York Legislature today to reject the Governor s p
Clinical Update - Debio 025 in Hepatitis C: Debiopharm Starts Phase IIb Triple Therapy Study, a Promising Therapeutic Avenue: PRNewswire - January 26, 2009; LAUSANNE, Switzerland , January 26/PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announced today the randomisation of its first patient in a phase IIb clinical study with Debio 025, a selective cyclop
AJWS Encouraged by Obama Move to Rescind Global Gag Rule: PRNewswire - January 24, 2009; NEW YORK, Jan. 24 /PRNewswire-USNewswire/ -- American Jewish World Service (AJWS) has applauded President Barack Obama for lifting the global gag rule, a ban on U.S. funding for family planning services provided by overseas NGOs offering abortion services or counseling as part of their programs. President Obama s decis
UNFPA Welcomes Restoration of U.S. Funding: PRNewswire - January 23, 2009; WASHINGTON, Jan. 23 /PRNewswire-USNewswire/ -- The United Nations Population Fund (UNFPA) applauds today s statement from United States President Barack Obama restoring U.S. funding for UNFPA s operations. President Obama said: I look forward to working with Congress to restore U.S. financial support for the U.N. Popul
Berman Calls Obama's Mexico City Policy Reversal an Important Step in Women's Rights, Health Care: PRNewswire - January 23, 2009; VAN NUYS, Calif., Jan. 23 /PRNewswire-USNewswire/ -- Congressman Howard L. Berman (D-CA), chairman of the House Foreign Affairs Committee, said today President Obama s executive order repealing the Mexico City Policy is an important step in protecting women s rights and in improving health care worldwide. The President
KRAVE Presents 4th Annual Naked Hearts To Raise Money for HIV/AIDS: PRNewswire - January 23, 2009; LAS VEGAS, Jan. 23 /PRNewswire/ -- Performers from Las Vegas biggest shows will be getting Naked this Valentine s Day to raise money for people with HIV/AIDS. The sexy, steamy, sultry event is the 4th Annual Naked Hearts, presented by KRAVE Nightclub and staged as a benefit for Las Vegas-based HIV/AIDS charity Golden R
Georgia Ranks Fourth in the Number of Untreated HIV Patients in the United States: PRNewswire - January 22, 2009; -- However, Georgia Remains a Difficult Target for Pharmaceutical Companies Wishing to Grow Their Patient Base, According to a New Analytics Tool From Decision Resources WALTHAM, Mass., Jan. 22 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms focusing on pharmaceutical and heal
Sir Elton John and David Furnish to Host 17th Annual Academy Awards(R) Viewing Party Benefiting the Elton John AIDS Foundation: PRNewswire - January 22, 2009; -- Chopard, Jo & Raffy Manoukian and Vh1 to Present this Year s Event LOS ANGELES, Jan. 22 /PRNewswire/ -- The 17th Annual Elton John AIDS Foundation (EJAF) Academy Awards(R) Viewing Party hosted by Sir Elton John and David Furnish will be held Sunday, February 22, 2009, at the Pacific Design Center and will be co-
Rx for Africa Ethiopia to Launch a Minimum of 36 New Products in 2009: Drugs for Malaria and HIV/AIDS a High Priority: PRNewswire - January 21, 2009; ADDIS ABABA, Ethiopia , Jan. 21 /PRNewswire-FirstCall/ -- Rx for Africa, Inc. s (Pink Sheets: RXAF.PK) wholly owned operating subsidiary, Rx Africa (Ethiopia) P.L.C. announced today that it s newly completed R&D center has formulated nine generic pharmaceuticals, and is on track to launch a minimum of 36 new produc
Rural Kenyans Recently Diagnosed as Being HIV Positive to Get Improved Medical Care at New Emusanda Health Centre: PRNewswire - January 18, 2009; -- Much Needed Health Facility Completed By The Vestergaard Frandsen Company KAKAMEGA, Kenya , January 18/PRNewswire/ -- A ribbon-cutting ceremony featuring Kenyan Deputy Prime Minister Musalia Mudavadi, South African musician Yvonne Chaka Chaka, and others was held today for the Emusanda Health Centre, marking the beg
WANTED: Global AIDS Coordinator - Requirements: Must Have Vision and a Commitment to Young People: PRNewswire - January 16, 2009; WASHINGTON, Jan. 16 /PRNewswire-USNewswire/ -- The following is a statement by James Wagoner, President of Advocates for Youth: -- Young people ages 15-25 represent 45 percent of all new HIV infections worldwide -- Almost a quarter of people living with HIV are under the age of 25 -- Young women comprise 57 percent of
ELLE, Fashion has its Heart in the Right Place!: PRNewswire - January 16, 2009; -- In a publishing first 30 Editions of Elle magazine team up with Bono, Gisele Bundchen and Scarlett Johansson in the fight against AIDS in Africa. NEW YORK, Jan. 16 /PRNewswire/ -- In just over 2 years, (PRODUCT)RED(TM) partners and events have generated over 120 million USD to help eliminate AIDS in Africa. Now, the
New Ad Sends Stark Warning About Dangers of Buying Fake Medicine: Hard-Hitting new Cinema Advert to Warn About Risks of Fake Medicine: PRNewswire - January 15, 2009; -- The First Collaboration of its Kind Between the Pharmaceutical Industry, Health Regulators and Patient Representatives to Combat the Threat Posed by Fake Medicine -- 330,000 Men in the UK Admit to Purchasing Prescription Only Medicine From Unregulated Sources(1) LONDON, January 15/PRNewswire/ -- A hard-hitting adver
PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine: PRNewswire - January 14, 2009; -- Largest Prospective Study Demonstrates Treatment Success, and Highlights Potential Factors that Affect Health Outcomes, in Latino Population Suffering from Chronic Hepatitis C - NUTLEY, N.J., Jan. 14 /PRNewswire/ -- Results from the LATINO study, the largest study conducted to-date in Latino patients with the hepati
PA Department of Health Urges Regular Screening for Sexually Transmitted Diseases: PRNewswire - January 14, 2009; -- STD Rates Rise Nationally; Many People May Not Realize They re Infected HARRISBURG, Pa., Jan. 14 /PRNewswire-USNewswire/ -- Pennsylvania saw an increase in the number of reported cases of gonorrhea and chlamydia in 2007, highlighting the need for more regular testing by men and women, according to the Department of
Annual CDC Report Finds High Burden of Sexually Transmitted Diseases, Especially Among Women and Racial Minorities: PRNewswire - January 13, 2009; PRNewswire-USNewswire - Jan. 13/ -- Reported cases of chlamydia and gonorrhea in the United States exceeded 1.4 million in 2007, according to an annual report (http://www.cdc.gov/std/stats07/) by the Centers for Disease Control and Prevention. These diseases continue to be the most commonly reported infectious diseases
Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients: PRNewswire - January 12, 2009; PRINCETON, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announced today that they and their development partner, Roche, have agreed with the FDA on the final design for a phase 2b trial with R7128, a nucleoside inhibitor of hepatitis C (HCV), slated to initiate in the first quarter of this yea
Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV): PRNewswire - January 12, 2009; CAMBRIDGE, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced that it has initiated a proof-of-concept study of IDX184, a liver-
Medical Clinic Owner Pleads Guilty to Role in $5.3 Million Medicare Fraud Scheme: PRNewswire - January 8, 2009; WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- The owner and operator of two Miami medical clinics has pleaded guilty to defrauding the Medicare program in connection with a $5.3 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney R. Alexander
Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008: PRNewswire - January 7, 2009; WALTHAM, Mass., Jan. 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE:IMA) , a leading provider of near-patient diagnostics, monitoring and health management solutions, has introduced the pima(TM) analyzer, a unique test platform which allows immunological testing at Point-of-Care. The initial appl
ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410: PRNewswire - January 7, 2009; FREDERICK, Md., Jan. 7 /PRNewswire/ -- ImQuest Life Sciences announced today the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor IQP-0410. ImQuest anticipates initiating their Phase 1 studies in the first quar
Global Action for Children Announces Half Million Dollar Grant From the Bill & Melinda Gates Foundation: PRNewswire - January 7, 2009; Grant to support Global Action for Children s work with African partners to ensure African governments meet commitments of 15 percent of national budget for health WASHINGTON, Jan. 7 /PRNewswire-USNewswire/ -- Global Action for Children (GAC) today announced that it has received a $500,000 grant from the Bill & Mel

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2009. AEGiS.